
        <html>
        <head>
            <style>
                body { font-family: Arial, sans-serif; line-height: 1.6; margin: 20px; }
                h3 { color: #333; }
                .question { margin-bottom: 15px; }
                .options { margin-left: 20px; margin-bottom: 10px; }
                .solution { background: #f8f9fa; padding: 10px; border-left: 4px solid #007bff; }
                .credits { text-align: center; margin-top: 20px; font-size: 18px; }
                .rainbow-text { 
                    background: linear-gradient(90deg, red, orange, yellow, green, blue, indigo, violet); 
                    -webkit-background-clip: text; 
                    color: transparent; 
                    font-weight: bold; 
                }
            </style>
        </head>
        <body>
        
            <div class="question">
                <h3>Question No: 1</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A 65-year-old patient admitted in a long-term care facility has developed pressure ulcer. On assessment, the nurse found that the bone is visible and palpable on the wound site. The nurse knows that the stage of the pressure ulcer is:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Stage-I</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Stage-II</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Stage-III</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Stage-IV</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>STAGES OF PRESSURE ULCER </strong></p>
<ul>
<li>Bedsores can happen when a person is bedridden or otherwise immobile, unconscious or unable to sense pain.</li>
<li>Bedsores are ulcers that happen on areas of the skin that are under pressure from lying in bed, sitting in a wheelchair or wearing a cast for a prolonged time.</li>
<li>Pressure score occurs if external pressure exceeds 30 mmHg of capillary occlusive pressure.</li>
<li>Tissue necrosis with prolonged pressure.</li>
<li>It is also known as Bed sores, pressure ulcers, Decubitus ulcers.</li>
<li>Incidence: 5% in hospitalized patient.</li>
<li><strong>Pressure sores are most common in: Ischium &gt; Greater trochanter &gt; Sacrum in the gluteal region</strong>.</li>
<li>After Gluteal region the site in order are: Heel &gt; Lateral malleoli &gt; occipital region.</li>
</ul>
<p><strong>&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Table: Classification of Pressure Sores</strong></p>
<table style="border-collapse: collapse; width: 100%; height: 1066px;" border="1">
<tbody>
<tr style="height: 99px;">
<td style="width: 12.4615%; height: 99px;" width="83">
<p><strong>Stage </strong></p>
</td>
<td style="width: 22.7692%; height: 99px;" width="150">
<p><strong>&nbsp;Description </strong></p>
</td>
<td style="width: 29.3846%; height: 99px;" width="194">
<p><strong>&nbsp; &nbsp;Cause </strong></p>
</td>
<td style="width: 35.3077%; height: 99px;" width="233">
<p><strong>&nbsp; Management </strong></p>
</td>
</tr>
<tr style="height: 262px;">
<td style="width: 12.4615%; height: 262px;" width="83">
<p><strong>1</strong></p>
</td>
<td style="width: 22.7692%; height: 262px;" width="150">
<p>Non-blanchable erythema without a breach in the epidermis</p>
</td>
<td style="width: 29.3846%; height: 262px;" width="194">
<ul>
<li>&nbsp; &nbsp;If the cause is direct pressure then either ensure that the patient&rsquo;s position is changed more frequently or &lsquo;step-up&rsquo; the pressure relief, e.g. move the patient from a static foam mattress to an alternating pressure mattress.</li>
</ul>
</td>
<td style="width: 35.3077%; height: 262px;" width="233">
<ul>
<li>&nbsp;The skin in a grade 1 pressure ulcer is not broken but it requires protection and monitoring.</li>
<li>&nbsp;Wound dressings for a grade 1 pressure ulcer should be simple and offer protection without risking any further skin damage, especially if the patient is sliding down the bed or chair causing the dressing to &lsquo;ruck&rsquo;.</li>
<li>&nbsp;&nbsp;&nbsp; A film dressing or a thin hydrocolloid would be appropriate to protect the wound area.</li>
<li>&nbsp;&nbsp;&nbsp; The slippery nature of these dressings may reduce further friction or shearing if these factors are involved.</li>
</ul>
</td>
</tr>
<tr style="height: 244px;">
<td style="width: 12.4615%; height: 244px;" width="83">
<p><strong>2</strong></p>
</td>
<td style="width: 22.7692%; height: 244px;" width="150">
<p>Partial-thickness skin loss involving the epidermis and dermis</p>
</td>
<td style="width: 29.3846%; height: 244px;" width="194">
<ul>
<li>&nbsp;&nbsp;&nbsp; If the pressure ulcer is circular, this is often an indication that direct pressure is the cause. In this case ensure that the patient&rsquo;s position is changed more frequently or &lsquo;step-up&rsquo; the level of pressure relief.</li>
<li>&nbsp;&nbsp;&nbsp; If the pressure ulcer is not uniform and is more widespread, then shearing or friction may be the cause.</li>
</ul>
</td>
<td style="width: 35.3077%; height: 244px;" width="233">
<ul>
<li>A grade 2 pressure ulcer is a superficial wound. If the wound has slough on the wound bed, <strong>debridement </strong>may be necessary.</li>
<li>&nbsp;&nbsp;&nbsp; There are many dressings that aid debridement, for example, hydrogels or hydrocolloids.</li>
<li>&nbsp;&nbsp;&nbsp; If protection is necessary as well as the promotion of a moist wound healing environment, a hydrocolloid or foam may be appropriate.</li>
<li>&nbsp;&nbsp;&nbsp; Dressing some areas may be a challenge like in sacral and heel region. So sacral flap is &nbsp;used.</li>
</ul>
</td>
</tr>
<tr style="height: 291px;">
<td style="width: 12.4615%; height: 291px;" width="83">
<p><strong>3</strong></p>
</td>
<td style="width: 22.7692%; height: 291px;" width="150">
<p>Full-thickness skin loss extending into the subcutaneous tissue but not through underlying fascia</p>
</td>
<td style="width: 29.3846%; height: 291px;" width="194">
<ul>
<li>&nbsp;&nbsp;&nbsp; The damaging factors (pressure, shear or friction) are continuing.</li>
<li>&nbsp;&nbsp;&nbsp; The dressings are not managing the exudate levels and the wound is getting bigger or deeper due to the destructive nature of chronic exudate</li>
<li>&nbsp;&nbsp;&nbsp; The pressure ulcer may be infected</li>
<li>&nbsp;&nbsp;&nbsp; The patient has a poor ability to heal, which may be due to poor circulation, inadequate nutrition, low hemoglobin levels or the presence of disease such as diabetes mellitus.</li>
</ul>
</td>
<td style="width: 35.3077%; height: 291px;" width="233">
<ul>
<li>&nbsp;&nbsp;&nbsp; As these pressure ulcers are substantially deep in many cases, the <strong>absorbency levels of the dressings may need to be increased</strong>.</li>
<li>&nbsp;&nbsp;&nbsp; <strong>Alginates and Foams absorbent dressings</strong> can be used in combination to increase the overall absorbency.</li>
<li>&nbsp;&nbsp;&nbsp; If this is occurring after the absorbent dressings, <strong>increase the dressing absorbency levels or the frequency of dressing</strong> changes.</li>
<li>&nbsp;&nbsp;&nbsp; If conventional dressings cannot manage the exudate, <strong>topical negative pressure therapy</strong> could be considered.</li>
</ul>
</td>
</tr>
<tr style="height: 170px;">
<td style="width: 12.4615%; height: 170px;" width="83">
<p><strong>4</strong></p>
</td>
<td style="width: 22.7692%; height: 170px;" width="150">
<p>Full-thickness skin loss through fascia with extensive tissue destruction, may be involving muscles, one, tendon or joint.</p>
</td>
<td style="width: 29.3846%; height: 170px;" width="194">
<ul>
<li>&nbsp;&nbsp;&nbsp; Grade 4 pressure ulcers are the deepest. It is essential to establish if or why the wound is deteriorating or if the depth of the wound is due to the initial pressure damage.</li>
</ul>
</td>
<td style="width: 35.3077%; height: 170px;" width="233">
<ul>
<li>&nbsp;&nbsp;&nbsp; The steps outlined under the <strong>treatment of grade 3</strong> pressure ulcers should be followed.</li>
<li>&nbsp;&nbsp;&nbsp; If there is bone exposed, consider infection in the bone (osteomyelitis). This can be identified using an X-ray or a magnetic resonance imaging (MRI) scans and is usually treatable with <strong>antibiotic therapy</strong>.</li>
</ul>
</td>
</tr>
</tbody>
</table>
<p><strong><br />Figure 1: </strong>Stages of Pressure Ulcer</p>
<p><img title="image002.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/f0b8c2cf-d889-47b6-be2f-3df2a865163e.jpg" alt="" width="350" height="223" /></p>
<ul>
<li><strong>Prevention is the best treatment: </strong>
<ul style="list-style-type: circle;">
<li>Bedridden patients be turned every 2 hours</li>
<li>Wheel chair patient should lift themselves every 10 minutes for 10 seconds.</li>
<li>Provide air mattress bedding.</li>
</ul>
</li>
<li><strong>Treatment: </strong>
<ul>
<li>Debridement</li>
<li>VAC devices at negative -<strong>125 mmHg suction pressure. </strong></li>
<li>Flaps</li>
</ul>
</li>
</ul>
<p><img title="image004.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/f109f99c-a42c-4b14-8251-769bad7db5de.jpg" alt="" width="254" height="197" /></p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Figure 2: </strong>Sacral dressing</p>
<p><strong>Clinical Pearls: </strong></p>
<ul>
<li>During dressing for pressure ulcers: Keep the ulcer tissue moist and surrounding skin dry.</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 2</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>During postoperative care of an infant with a cleft palate repair, the nurse should position the baby in which of the following positions?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>On side lying position</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>In an infant seat</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Prone</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Supine</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Cleft lip and cleft palate are openings or splits in the upper lip, the roof of the mouth (palate) or both.</li>
<li>Cleft lip repair, usually performed by a plastic surgeon, is a major part of the treatment of a newborn with cleft lip, palate or both; some surgeons favor early repair, before the newborn is discharged from the hospital; other surgeons prefer to wait until the newborn is 1 to 2 months old, weighs about 10 lbs and is gaining weight steadily.</li>
<li>Child who has had a cleft lip repair should be positioned on their side or back to keep them from rubbing their face in the bed.</li>
<li>A child with only a cleft palate repair may sleep on their stomach. It is important to keep the stitches clean and without crusting.</li>
<li><strong>Nursing interventions for the patient with cleft lip and palate are:</strong>
<ul style="list-style-type: circle;">
<li><strong>Maintain adequate nutrition:</strong> Breastfeeding may be successful because the breast tissue may mold to close the gap; if the newborn cannot be breastfed, the mother&rsquo;s breast milk may be expressed and used instead of formula; a soft nipple with a cross-cut made to promote easy flow of milk may work well.</li>
<li><strong>Positioning:</strong> If the cleft lip is unilateral, the nipple should be aimed at the unaffected side; the infant should be kept in an upright position during feeding.</li>
<li><strong>Tools for feeding:</strong> Lamb&rsquo;s nipples (extra-long nipples) and special cleft palate nipples molded to fit into the open palate area to close the gap may be used; one of the simplest and most effective methods may be the use of an eyedropper or an Asepto syringe with a short piece of rubber tubing on the tip (Breck feeder).</li>
<li><strong>Promote family coping:</strong> Encourage the family to verbalize their feelings regarding the defect and their disappointment; serve as a model for the family caregiver&rsquo;s attitudes toward the child.</li>
<li><strong>Reduce family anxiety:</strong> Give the family information about cleft repairs; encourage them to ask questions and reassure them that any question is valid.</li>
<li><strong>Provide family teaching:</strong> Explain the usual routine of preoperative, intraoperative and post-operative care; written information is helpful, but be certain the parents understand the information.</li>
</ul>
</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 3</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>What is the color coding of the bag used in hospitals to &lsquo;dispose off&rsquo; human anatomical wastes such as body parts? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Red</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Black</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Yellow</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Blue</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><img title="image007.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/7f757053-de1d-49c0-853e-aac83d9770f5.png" alt="" width="388" height="220" /></p>
<p><strong>Figure: </strong>Biomedical Waste Management &nbsp;</p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 4</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The vaccine that forms blister and leaves permanent scar in babies is:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>DPT</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>BCG</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Measles</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Pentavalent</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>BCG (TB) vaccine side effects</strong></p>
<ul>
<li>Reactions to the BCG vaccine are uncommon and generally mild.</li>
<li>The most common side effects include fever, headache and swollen glands.</li>
<li>More serious complications, such as abscesses or bone inflammation, are rare.</li>
<li>Most children develop a sore at the injection site. Once healed, the sore may leave a small scar. This is normal and nothing to worry about.</li>
</ul>
<p><strong>BCG vaccination scar</strong></p>
<ul>
<li>Virtually everyone when given the BCG vaccination will develop a raised bubble at the site of the injection, which may disappear soon afterwards.</li>
<li>About 2 to 6 weeks after the injection, a small spot may appear at the site of the injection.</li>
<li>It is normal for the spot to turn into a blister, which sometimes oozes before becoming a crusty scab.</li>
<li>It's important to leave the area uncovered as the air will help it to heal. It is normal for it to leave a small scar.</li>
<li>Occasionally, there may be a more severe skin reaction, but this should heal within several weeks.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 5</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Identify the Device/ Instrument shown in the photograph:</strong></p>
<p><strong><img title="image009.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/36b3eaae-6472-4326-91e9-4e499b8575f9.png" alt="" width="293" height="100" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Doyen&rsquo;s retractor</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Deavor retractor</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Anterior vaginal wall retractor</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>HSG cannula</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p>The given image is Doyen&rsquo;s Retractor.</p>
<p><img title="image011.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/eaa69d9e-1b07-4399-ae29-70b6da56190c.png" alt="" width="252" height="111" /></p>
<p><strong>Figure: </strong>Doyen&rsquo;s Retractor</p>
<ul>
<li><strong>Material:</strong> Stainless steel</li>
<li><strong>Sterilization:</strong> Autoclaving</li>
<li><strong>Uses: </strong></li>
<li><strong>Obstetric</strong></li>
<li><strong><em>Cesarean section</em></strong></li>
<li>Cesarean hysterectomy</li>
<li>Exploratory laparotomy for ruptured tubal ectopic pregnancy</li>
<li><strong>Gynecologic</strong></li>
<li><strong><em>Abdominal hysterectomy</em></strong></li>
<li><strong><em>Wertheim&rsquo;s hysterectomy</em></strong></li>
<li>Tuboplasty</li>
<li>Sling operation</li>
<li>Purandare&rsquo;s cervicopexy</li>
<li>Exploratory laparotomy for ovarian tumors</li>
<li>Myomectomy</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 6</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The pelvic shape that has the poorest prognosis from vaginal delivery _____________:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Platypelloid</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Anthropoid</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Android</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Gynecoid</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Android pelvis </strong></p>
<p><strong>&nbsp;</strong><strong> <img src="data:image/jpeg;base64,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" /></strong></p>
<p><strong>&nbsp;</strong><strong>Figure 1: </strong>Android Pelvis</p>
<ul>
<li>Male type pelvis.</li>
<li>Heart shape.</li>
<li><strong>Transverse diameter is &gt; AP diameter</strong></li>
<li><strong>Subpubic angle:</strong> &lt; 90&deg;</li>
<li>Engagement is delayed.</li>
<li><strong>Deep transverse arrest/persistent occipito posterior position common</strong>.</li>
<li><strong>Type of delivery:</strong> Difficult instrumental delivery.</li>
</ul>
<p><strong>Gynecoid pelvis</strong></p>
<p><img title="image013.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/b6ac00c4-e4c2-438b-bd65-42107ddaf65c.jpg" alt="" width="200" height="153" /></p>
<p><strong>Figure 2: </strong>Gynecoid Pelvis</p>
<ul>
<li>Female type M/C variety</li>
<li>Transverse oval</li>
<li>Transverse diameter of inlet is slightly bigger than AP diameter</li>
<li><strong>Subpubic angle:</strong> 90&deg;</li>
<li>Normal female pelvis</li>
<li>No difficulty in engagement</li>
<li>M/C position of head LOT/LOA</li>
<li><strong>Type of delivery:</strong> Normal delivery</li>
</ul>
<p><strong>Anthropoid pelvis</strong></p>
<p><strong><img title="image014.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/4351883b-2e43-43c7-bbca-a2bb10d7e0e8.jpg" alt="" width="200" height="162" /></strong></p>
<p><strong>Figure 3: </strong>Anthropoid Pelvis</p>
<ul>
<li>Ape like pelvis</li>
<li>AP oval only pelvis with - <strong>AP diameter &gt; transverse diameter</strong></li>
<li><strong>Diameter of engagement</strong> is AP diameter</li>
<li><strong>Direct occipitoposterior position is M/C</strong></li>
<li>Non-rotation is common</li>
<li><strong>Type of delivery:</strong> Face to pubes delivery</li>
</ul>
<p><strong>Platypelloid pelvis</strong></p>
<p><strong><img title="image016.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/5d4ce9c6-3211-495f-89f2-1d26dffaa260.jpg" alt="" width="200" height="127" /></strong></p>
<p><strong>Figure 4: </strong>Platypelloid Pelvis</p>
<ul>
<li>Flat pelvis least common variety</li>
<li>Flat bowl like</li>
<li>Pelvis with - Transverse diameter &gt;&gt;&gt; (much more than AP diameter)</li>
<li>Head engages in transverse diameter with marked asynclitism</li>
<li>Engaging diameter is super subparietal diameter (18.5 cm) instead of usual biparietal diameter (9.5)</li>
<li><strong>Type of delivery:</strong> If head is able to negotiate the inlet by means of asynclitism &rarr; Normal labor otherwise cesarean section.</li>
</ul>
<p><strong>Important points on pelvis</strong></p>
<ul>
<li>Normal female pelvis &ndash; Gynecoid pelvis.</li>
<li>Male type pelvis &ndash; Android pelvis.</li>
<li>Most common type of pelvis &ndash; Gynecoid pelvis.</li>
<li>Least common type pelvis &ndash; Platypelloid pelvis.</li>
<li>The only pelvis with AP diameter more than transverse diameter &ndash; Anthropoid pelvis.</li>
<li>Face to pubes delivery is most common in Anthropoid pelvis.</li>
<li>Direct occipitoposterior position is most common in Anthropoid pelvis.</li>
<li>Persistent occipitoposterior position is most common in Android pelvis.</li>
<li>Deep transverse arrest/ Non-rotation/Dystocia is most common in Android pelvis.</li>
<li>Broad flat pelvis &ndash; Platypelloid pelvis.</li>
<li>Transverse diameter is much more than AP diameter &ndash; Platypelloid pelvis.</li>
<li>Engagement by exaggerated posterior asynclitism occurs in platypelloid pelvis.</li>
<li>Super subparietal instead of biparietal diameter engages in platypelloid pelvis.</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 7</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following colored IV cannula is used for infant?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Grey</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Pink</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Yellow</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Green</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Color-Coding of IV cannulas </strong></p>
<p><img src="data:image/jpeg;base64,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" /></p>
<p>&nbsp; &nbsp; &nbsp; &nbsp; <strong>&nbsp;Figure:</strong> Commonly used IV cannula</p>
<p><strong>Table: Color Coding of IV Cannula<br /></strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 100%;" colspan="6">
<p><strong>Table: Color Coding of IV Cannula</strong></p>
</td>
</tr>
<tr>
<td style="width: 11.8705%;">
<p>Color</p>
</td>
<td style="width: 7.55396%;">
<p>Size</p>
</td>
<td style="width: 16.5468%;">
<p><strong>External diameter (mm)* </strong></p>
</td>
<td style="width: 12.7698%;">
<p><strong>Length (mm)* </strong></p>
<p>&nbsp;</p>
</td>
<td style="width: 17.8058%;">
<p><strong>Water flow rate (ml/min)* </strong></p>
</td>
<td style="width: 33.4532%;">
<p><strong>Recommended uses </strong></p>
</td>
</tr>
<tr>
<td style="width: 11.8705%;">
<p>Orange</p>
</td>
<td style="width: 7.55396%;">
<p>14G</p>
</td>
<td style="width: 16.5468%;">
<p>2.1 mm</p>
</td>
<td style="width: 12.7698%;">
<p>45 mm</p>
</td>
<td style="width: 17.8058%;">
<p>~240 mL/min</p>
</td>
<td style="width: 33.4532%;">
<p>Trauma, Rapid blood transfusion, Surgery</p>
</td>
</tr>
<tr>
<td style="width: 11.8705%;">
<p>Gray</p>
</td>
<td style="width: 7.55396%;">
<p>&nbsp;</p>
<p>16G</p>
</td>
<td style="width: 16.5468%;">
<p>1.8 mm</p>
</td>
<td style="width: 12.7698%;">
<p>&nbsp;</p>
<p>45 mm</p>
</td>
<td style="width: 17.8058%;">
<p>~180 mL/min</p>
<p>&nbsp;</p>
</td>
<td style="width: 33.4532%;">
<p>Rapid fluid replacement, Trauma, Rapid blood transfusion</p>
</td>
</tr>
<tr>
<td style="width: 11.8705%;">
<p>Green</p>
</td>
<td style="width: 7.55396%;">
<p>18G</p>
</td>
<td style="width: 16.5468%;">
<p>1.3 mm</p>
</td>
<td style="width: 12.7698%;">
<p>32 mm</p>
</td>
<td style="width: 17.8058%;">
<p>~90 mL/min</p>
</td>
<td style="width: 33.4532%;">
<p>Rapid fluid replacement, Trauma, Rapid blood transfusion</p>
</td>
</tr>
<tr>
<td style="width: 11.8705%;">
<p>Pink</p>
</td>
<td style="width: 7.55396%;">
<p>&nbsp;</p>
<p>20G</p>
</td>
<td style="width: 16.5468%;">
<p>1.1 mm</p>
</td>
<td style="width: 12.7698%;">
<p>&nbsp;</p>
<p>32 mm</p>
</td>
<td style="width: 17.8058%;">
<p>~60 mL/min</p>
<p>&nbsp;</p>
</td>
<td style="width: 33.4532%;">
<p>Most infusions, Rapid fluid replacement, Trauma, Routine blood transfusion</p>
</td>
</tr>
<tr>
<td style="width: 11.8705%;">
<p>Blue</p>
</td>
<td style="width: 7.55396%;">
<p>22G</p>
</td>
<td style="width: 16.5468%;">
<p>0.9 mm</p>
</td>
<td style="width: 12.7698%;">
<p>25 mm</p>
</td>
<td style="width: 17.8058%;">
<p>~36 mL/min</p>
</td>
<td style="width: 33.4532%;">
<p>Most infusions, neonate, pediatric, older adults, routine blood transfusion</p>
</td>
</tr>
<tr>
<td style="width: 11.8705%;">
<p>Yellow</p>
</td>
<td style="width: 7.55396%;">
<p>24G</p>
</td>
<td style="width: 16.5468%;">
<p>0.7 mm</p>
</td>
<td style="width: 12.7698%;">
<p>19 mm</p>
</td>
<td style="width: 17.8058%;">
<p>~20 mL/min</p>
</td>
<td style="width: 33.4532%;">
<p>Most infusions neonate, pediatric, older adults, Routine blood transfusion, Neonate or Pediatric blood transfusion</p>
</td>
</tr>
<tr>
<td style="width: 11.8705%;">
<p>Purple</p>
</td>
<td style="width: 7.55396%;">
<p>26G</p>
</td>
<td style="width: 16.5468%;">
<p>0.6 mm</p>
</td>
<td style="width: 12.7698%;">
<p>19 mm</p>
</td>
<td style="width: 17.8058%;">
<p>~13 mL/min</p>
</td>
<td style="width: 33.4532%;">
<p>Pediatrics, Neonate</p>
</td>
</tr>
</tbody>
</table></li></ul></div></div>
            <div class="question">
                <h3>Question No: 8</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>What is the cerebral tissue perfusion pressure if Blood Pressure is 90/60 and ICP is 18?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>42 mmHg</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>52 mmHg</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>60 mmHg</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>72 mmHg</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Cerebral perfusion is a high flow, low pressure system with relatively preserved diastolic flow. This can be appreciated by comparing doppler waveforms from cerebral vessels with systemic vessels; the ratio of diastolic to systolic flow is much higher for the cerebral circulation.</li>
<li>Monitoring cerebral perfusion pressure requires measuring both the MAP and the ICP. The MAP can be measured directly through invasive hemodynamic means, most often cannulation of a peripheral artery such as the radial or femoral artery.</li>
</ul>
<p>CPP = MAP - ICP</p>
<p>MAP = [SBP + 2(DBP)]/3</p>
<p>MAP = [90 +2 (60)]/3</p>
<p>= 210/3</p>
<p>MAP = 70 mmHg</p>
<p>CPP = MAP &ndash; ICP</p>
<p>= 70 - 18</p>
<p>= 52 mmHg</p>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 9</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Identify the instrument given in the image:</strong></p>
<p><strong><img title="image024.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/42bf1fb7-5ae2-4509-b0aa-f9a66f4b5547.png" alt="" width="221" height="134" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Surgical scissor</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Episiotomy scissor</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Cord cutting scissor</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Mayo scissor</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Episiotomy scissor</strong></p>
<ul>
<li>The angulation in the scissor is to prevent extension of pelvic tear into the anal margins and obstetrics, anal sphincter injuries/complete perianal tear.</li>
<li><strong>Structure involved in Episiotomy:</strong>
<ul style="list-style-type: circle;">
<li>Vagina mucosa</li>
<li>Superficial and deep transverse perineal muscles, bulbospongiosus, levator ani muscles</li>
<li>Internal pudendal blood vessels</li>
<li>Subcutaneous tissue and perineal skin</li>
</ul>
</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 10</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Murphy&rsquo;s sign is seen in which of the following disease condition?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Liver abscess</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Splenomegaly</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Peritonitis</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Acute cholecystitis</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>In the acute phase of cholecystitis, the patient may have right upper quadrant tenderness that is exacerbated during inspiration by the examiner&rsquo;s right subcostal palpation (murphy&rsquo;s sign).</li>
<li>Place the hand below right costal margin along the, mid-Clavicular line. Ask the patient to breath in deep. Patient experiences pain at the peak of inspiration.</li>
</ul>
<p><img title="image026.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/f2b74511-b0d5-4a6b-ad85-e349e62e3c5f.png" alt="" width="165" height="158" /></p>
<p><strong>Figure: </strong>Murphy&rsquo;s Sign</p>
<ul>
<li>Moynihan&rsquo;s Modification of eliciting Murphy&rsquo;s sign using left thumb.</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 11</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following gas has most pungent smelling?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Sevoflurane</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Isoflurane</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Both are equally pungent</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Benzene</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Isoflurane is a clear, colorless, stable liquid containing no additives or chemical stabilizers. Isoflurane has a mildly pungent, musty, ethereal odor.</li>
<li>The irritability grading was: Desflurane &gt; Isoflurane &gt; Sevoflurane.</li>
<li>Sevoflurane is the least irritating agent for inhalation.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 12</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A 7-year-old child intermittently bedwetting at least 2 times a week. The nurse anticipates which of the following drug to be prescribed by the physician?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Desmopressin</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Diazepam</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Methylphenidate</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Fluoxetine</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Desmopressin: A synthetic analog of arginine vasopressin, desmopressin works by decreasing urine volume at night and by decreasing intravesicular pressure. The drug comes in a nasal spray or tablet. Treatment using the nasal spray is initiated with 10 mcg given at bedtime, one half of the dose in each nostril.</li>
<li>Imipramine is a class of medications called tricyclic antidepressants.</li>
<li>Imipramine is used to treat depression. Imipramine is also used to prevent bedwetting in children, but it not preferred nowadays due to toxicity.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 13</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Identify the equipment given in the image:</strong></p>
<p><strong><img title="image028.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/f70dd79b-b262-4b06-9183-8e10b70d3e82.png" alt="" width="239" height="132" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Nasopharyngeal airway</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Guedel airway</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Tracheostomy tube</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Tongue depressor</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Oropharyngeal Airway (Guedel Oropharyngeal Airway)</strong></p>
<p><img title="image030.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/17f14b05-08c3-46de-9b71-0d7113a07545.png" alt="" width="462" height="217" /></p>
<p><strong>Figure 1: </strong>Guedel Oropharyngeal Airway</p>
<p><img title="image032.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/4356d299-ab47-4f93-90c6-64fd51e5025a.jpg" alt="" width="305" height="231" /></p>
<p><strong>Figure 2: </strong>Different Sizes of Oropharyngeal Airway</p>
<p><strong>Indications</strong></p>
<ul>
<li>Bilateral choanal atresia</li>
<li>In condition where there is tendency of tongue fall back</li>
<li>Persistent seizure</li>
<li>Status epilepticus.</li>
</ul>
<p>&nbsp;</p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 14</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The leading anatomical part of the fetus closest to the pelvic inlet of the birth canal refers to: </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Presentation</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Lie</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Denominator</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Position</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Presentation</strong>: This refers to the part of the fetus that is closest to the cervix and pelvic inlet during labor. The most common types of presentation are:</p>
<ul>
<li><strong>Cephalic</strong>: The head is the presenting part (most common).</li>
<li><strong>Breech</strong>: The buttocks or feet are presenting.</li>
<li><strong>Shoulder</strong>: The shoulder is presenting, which is less common.</li>
</ul>
<ul>
<li>A breech presentation is when the fetus presents buttocks or feet first (rather than head first &ndash; a cephalic presentation). It has significant implications in terms of delivery &ndash; especially if it occurs at term (&gt;37 weeks&rsquo;).</li>
<li>Breech presentation is defined as a fetus in a longitudinal lie with the buttocks or feet closest to the cervix. This occurs in 3 - 4% of all deliveries.</li>
<li><strong>Lie</strong>: This describes the relationship of the long axis of the fetus to the long axis of the mother. The two main types of lie are:</li>
<li><strong>Longitudinal</strong>: The fetus is oriented vertically (head or buttocks up).</li>
<li><strong>Transverse</strong>: The fetus is oriented horizontally.</li>
<li><strong>Denominator</strong>: This term usually refers to a specific landmark on the presenting part of the fetus that helps in determining its position. For example, in a cephalic presentation, the occiput (the back of the head) is often used as the denominator.</li>
<li><strong>Position</strong>: This describes the specific orientation of the presenting part relative to the mother's pelvis. It is usually expressed in terms of the fetal back's position (anterior, posterior, or lateral) in relation to the mother's pelvis.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 15</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The diameter that is being assessed in the given image is:</strong></p>
<p><strong><img title="image034.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/37e906b5-cd4d-4d9c-b531-2b278fe03dbb.jpg" alt="" width="221" height="191" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Obstetrical conjugate</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Anatomical conjugate</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>True conjugate</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Diagonal conjugate</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Normal female Pelvis </strong></p>
<ul>
<li>The female pelvis provides the basic framework of the birth canal.</li>
<li><strong>Composed of: </strong></li>
<li>Paired innominate bones: ilium, ischium, pubis (fuse in adolescence) &mdash;&gt; join anteriorly (symphysis pubis)</li>
<li>Sacrum: 5 - 6 fused vertebrae (join with innominate bones via sacroiliac joints)</li>
<li>The obstetric pelvis is divided into false and true pelvis by the pelvic brim or inlet.</li>
<li><strong>Divided into (by linea terminalis)</strong></li>
</ul>
<p><strong><img title="image036.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/04e37772-fd71-4aa5-b305-df49cb9c718d.jpg" alt="" width="460" height="302" /></strong></p>
<p><strong>Figure 1: </strong>Bony pelvis<strong> </strong></p>
<ul>
<li><strong>Greater pelvis (false) &rarr;</strong>&nbsp;Distributes weight of abdominal organs and gravid uterus (see Figure orange). It is formed by iliac portio of innominate bones. Shallow portion above the pelvic brim. Its only function is to support enlarged uterus during pregnancy.</li>
<li><strong>Lesser pelvis (true) &rarr;</strong>&nbsp;Contains pelvic viscera (see Figure, purple). It is shallow in front, formed by symphysis pubis, deep posteriorly formed by sacrum and coccyx. It consists of inlet, cavity and outlet.</li>
</ul>
<p><strong>Pelvic diameter:</strong> Important measurements in obstetrics</p>
<p><img title="image038.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/36ea05fb-bf20-46da-8ce1-911b0bc5afdd.jpg" alt="" width="314" height="322" /></p>
<p><strong>&nbsp;Figure 2: </strong>Clinical pelvimetry</p>
<ul>
<li><strong>Pelvic inlet</strong>
<ul>
<li><strong>Obstetric conjugate:</strong> should be 10 to 10.5 cm.</li>
</ul>
</li>
<li>Narrowest fixed distance that fetal head passes through during birth</li>
<li>Cannot measure directly on pelvic exam</li>
<li>Obstetric conjugate normally measures 10 cm or more</li>
<li>The pelvic inlet is considered to be contracted, if obstetric conjugate is less than 10 cm.
<ul>
<li><strong>Diagonal conjugate: 12.5 cm</strong></li>
</ul>
</li>
<li>Used as surrogate measure for above (obstetric conjugate)</li>
<li>Distance between lower border of pubis and sacral promontory (at level of ischial spines)</li>
<li>Must be &gt; 11.5 cm to accommodate fetal head</li>
</ul>
<p><strong>Transverse Diameter of Pelvic Inlet</strong> (13 to 13.5 cm)</p>
<ul>
<li style="list-style-type: none;">
<ul>
<li>It is the distance between the farthest two points on the iliopectineal line. It is the largest diameter of the pelvic inlet and lies 4 cm anterior to the promontory and 7 cm behind the symphysis.</li>
</ul>
</li>
<li><strong>Midpelvis</strong>
<ul>
<li>Interspinous diameter: distance between ischial spines</li>
<li>Should be &gt; 10 cm</li>
</ul>
</li>
<li><strong>True conjugate or anatomical conjugate (11 cm):</strong> This is measured from the midpoint of sacral promontory to the upper border of pubic symphysis.</li>
<li><strong>Oblique Diameters of Pelvic Inlet:</strong> There are two oblique diameters, right and left (12 cm). The right oblique diameter passes from right sacroiliac joint to the left iliopubic eminence, whereas the left diameter passes from left sacroiliac joint to the right iliopubic eminence.</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 16</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following color bag is used to discard resection of gangrene part of the patient?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Red</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Blue</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Yellow</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Black</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Biomedical Waste Management </strong></p>
<ol>
<li><strong> </strong> <strong>Yellow Bag </strong></li>
</ol>
<p><img title="image040.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/e15983dd-a5c4-4114-8678-f113793138d5.jpg" alt="" width="210" height="215" /></p>
<p><strong>Figure 1: </strong>Yellow Bag</p>
<ul>
<li><strong>Human Anatomical Waste:</strong> Human tissue, organs, body parts, fetus</li>
<li><strong>Animal Waste:</strong> Animal tissues, body parts, organs, carcasses, fluids, blood</li>
<li><strong>Soiled Waste:</strong> Items contaminated with blood and fluids, including cotton, dressings, soiled plaster casts, linen and beddings.</li>
<li><strong>Discarded Medicine and Cytotoxic Drugs:</strong> Outdated contaminated and discarded drugs.</li>
<li><strong>Chemical Waste:</strong> Chemical used in disinfection (insecticides) or in production of biological.</li>
<li><strong>Chemical Liquid Waste:</strong> Waste generated from lab and washing, cleaning, housekeeping and disinfecting activities.</li>
<li><strong>Microbiology and Biotechnology Waste:</strong> Waste from lab cultures, stocks, specimens of microorganisms, live or attenuated vaccine, cell cultures (Human/Animal), wastes from production of biological toxins.</li>
</ul>
<ol start="2">
<li><strong> </strong> <strong>Red Bag</strong></li>
</ol>
<p><img title="image041.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/87907b1f-56e6-4658-a938-eb7c60b3733b.jpg" alt="" width="215" height="215" /></p>
<p><strong>Figure 2: </strong>Red Bag</p>
<ul>
<li><strong>Contaminated Waste (Recyclable):</strong> Disposable items (except sharps) including tubing, catheters, intravenous tubes and sets, urine bags, syringes (without needles and fixed needle syringes) and vacutainer with needle cut and gloves.</li>
</ul>
<ol start="3">
<li><strong> </strong><strong>White Bag</strong></li>
</ol>
<p><strong><img title="image042.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/731abcc9-8fea-4abc-ad04-ec035df4a3ee.jpg" alt="" width="166" height="215" /></strong></p>
<p><strong>Figure 3: </strong>White Bag</p>
<ul>
<li><strong>Waste Sharps:</strong> Needles, syringes, blades, scalpels, glass</li>
</ul>
<p><strong>4.&nbsp; Blue Bag</strong></p>
<p><img title="image044.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/e34b3f6e-573d-4153-ae5c-67d8e6e6be11.jpg" alt="" width="112" height="126" /> &nbsp; <img title="image045.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/60dd3cbc-f36d-48f9-8861-2d02889bb49d.jpg" alt="" width="212" height="129" /></p>
<p><strong>Figure 4: </strong>Blue Bag</p>
<ul>
<li><strong>Glassware, Metallic Body implants:</strong> Broken or discarded and contaminated</li>
</ul>
<ol start="5">
<li><strong> </strong> <strong>Black Bag </strong></li>
</ol>
<p><img title="image046.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/60d397d9-ad80-47b1-9d2e-4c8fefbfa077.jpg" alt="" width="167" height="181" /></p>
<ul>
<li>Wrapper of surgical syringe constitutes non-infectious waste for municipal dump &rarr; hence, discarded in black bag.</li>
<li>Non-infectious wastes are disposed of in black bags (Municipal waste).</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 17</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Jackson Pratt drain was used in all of the following surgery, except:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Thoracic surgery</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Head and neck surgery</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Abdominal surgery</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Breast reduction and breast reconstruction surgery</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p>While Jackson Pratt drains can be used in various surgeries to help remove fluids, they are less commonly used in thoracic surgeries compared to other types, such as abdominal or head and neck surgeries, where fluid accumulation is a greater concern.</p>
<ul>
<li>A Jackson Pratt drain is used to help empty excess fluid from the body after surgery. Use of a drain can help in the healing process.</li>
</ul>
<p><img src="data:image/jpeg;base64,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" width="358" height="241" /></p>
<p><strong>Figure: Jackson Pratt drain</strong></p>
<ul>
<li>After surgery, there is continued oozing and shedding of cells and bodily fluids at the surgical site. The Jackson Pratt drain removes fluid and this removal of fluid speeds healing.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 18</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Oral white patches which is commonly seen in infant which bleeds on touching is seen in:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Pancytopenia</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Leukoplakia</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Leucopenia</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Myeloma</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Leukoplakia in infants may manifest as white or gray patches inside the mouth. This condition can result from various factors, such as oral candidiasis, retained milk, and geographic tongue.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 19</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following is a function of fallopian tube?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Implantation</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Fertilization</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Sperm production</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Ovum production</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>The fallopian tubes are bilateral conduits between the ovaries and the uterus in the female pelvis. They function as channels for oocyte transport and fertilization. Given this role, the fallopian tubes are a common etiology of infertility as well as the target of purposeful surgical sterilization.</li>
<li>The implantation normally takes place in the superior and posterior walls of the uterine body (corpus uteri) in the functional layer of the endometrium during the secretory phase of the cycle. Normal implantation zone of the blastocyst in the superior and posterior wall of the uterine cavity.</li>
<li>Sperm production takes place inside the seminiferous tubules, which is a convoluted cluster of tubes located inside the testes. Testosterone production occurs in cells surrounding the seminiferous tubules, called Leydig cells.</li>
<li>The ovaries produce the egg cells, called the ova or oocytes. The oocytes are then transported to the fallopian tube where fertilization by a sperm may occur. The fertilized egg then moves to the uterus, where the uterine lining has thickened in response to the normal hormones of the reproductive cycle.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 20</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>What is the normal CVP pressure?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1 &ndash; 2 mmHg</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>2 &ndash; 6 mmHg</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>3 &ndash; 8 mmHg</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>5 - 8 mmHg</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Central venous pressure (CVP) is the blood pressure in the venae cavae, near the right atrium of the heart. CVP reflects the amount of blood returning to the heart and the ability of the heart to pump the blood back into the arterial system.</li>
<li>A normal central venous pressure reading is between 2 to 6 mmHg. This value is altered by volume status and/or venous compliance.</li>
<li>CVP is elevated by over hydration which increases venous return. Heart failure or PA stenosis which limit venous outflow and lead to venous congestion.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 21</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Identify the size of scalpel blade in the following image:</strong></p>
<p><strong><img title="image049.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/99b5a51f-8c3c-47a3-9b06-e6d73a66729b.jpg" alt="" width="228" height="104" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>10</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>11</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>12</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>13</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Surgical blades are typically made with stainless steel or carbon steel.</li>
<li>Surgical blade designed in a manner to avoid the maximum deep cut while using.</li>
<li>The main difference between the normal blade to the surgical blade is in the design matter of a surgical blade, that can&rsquo;t allow cutting any structure within a cut.</li>
<li>Blades number 10, 11, 12 and 15 fit in BP (<strong>Bard Parker&rsquo;s</strong>) handle number 3, 5 and 7.</li>
<li>Blade numbers 18, 19, 20, 21, 22, 23, 24 fit in BP (<strong>Bard Parker&rsquo;s</strong>) handle number 4.</li>
</ul>
<p><img title="11.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/8770e929-73b6-42b9-ac6e-dcdfd25b1047.png" alt="" width="666" height="294" /></p>
<p><strong>Figure: Blade Sizes </strong></p>
<ul>
<li>The blades are detachable and a new blade is used for every patient.</li>
</ul>
<p><strong>Table: Identification of the blade</strong></p>
<table style="border-collapse: collapse; width: 87.6122%; height: 706px;" border="1">
<tbody>
<tr>
<td style="width: 18.1655%;" width="106">
<p><strong>Size 10</strong></p>
</td>
<td style="width: 81.8345%;" width="558">
<p>It has a large curved cutting edge is one of the more traditional blade shapes.</p>
</td>
</tr>
<tr>
<td style="width: 18.1655%;" width="106">
<p><strong>Size 11</strong></p>
</td>
<td style="width: 81.8345%;" width="558">
<p>It is an elongated, triangular blade sharpened along the hypotenuse edge. It has a pointed tip making it ideal for stab incisions and precise short cuts in shallow recessed areas.</p>
</td>
</tr>
<tr>
<td style="width: 18.1655%;" width="106">
<p><strong>Size 12</strong></p>
</td>
<td style="width: 81.8345%;" width="558">
<p>Small, pointed crescent-shaped blade sharpened along the inside edge of the curve.</p>
</td>
</tr>
<tr>
<td style="width: 18.1655%;" width="106">
<p><strong>Size 15 </strong></p>
</td>
<td style="width: 81.8345%;" width="558">
<p>It has a small, curved cutting edge ideal for making short, precise incisions.</p>
</td>
</tr>
<tr>
<td style="width: 18.1655%;" width="106">
<p><strong>Size 20</strong></p>
</td>
<td style="width: 81.8345%;" width="558">
<p>A large curved blade commonly used for cutting tissue and other procedures that require a puncture or cut.</p>
</td>
</tr>
<tr>
<td style="width: 18.1655%;" width="106">
<p><strong>Size 22</strong></p>
</td>
<td style="width: 81.8345%;" width="558">
<p>It is a larger version of the number 10 blade with a curved cutting edge and a flat, unsharpened back edge.</p>
</td>
</tr>
<tr>
<td style="width: 18.1655%;" width="106">
<p><strong>Size 23</strong></p>
</td>
<td style="width: 81.8345%;" width="558">
<p>Similar to size 22, leaf-shaped. It also has a pointier tip.</p>
</td>
</tr>
<tr>
<td style="width: 18.1655%;" width="106">
<p><strong>Size 24 </strong></p>
</td>
<td style="width: 81.8345%;" width="558">
<p>A wide, flat, angled cutting edge.</p>
</td>
</tr>
</tbody>
</table>
<ul>
<li><strong>Uses:</strong>
<ul>
<li><strong>Size 10:</strong> For making the skin incision.</li>
<li><strong>Size 11:</strong> Used for arteriotomy and incision and <strong>drainage of abscess</strong>. Used in anesthesia practices in the CVP-Central Venous pressure catheter placement and in femoral dialysis catheter insertion.</li>
<li><strong>Size 12:</strong> Used as a suture cutter.</li>
<li><strong>Size 15:</strong> The blade designed in a manner to make a small incision for minimal skin damage. Used for minor surgical procedure and in <strong>Ophthalmology surgery</strong> for the incision</li>
<li><strong>Size 20:</strong> Used in abdominal surgery for the continuous incision. Used in general surgery and orthopedic surgery.</li>
<li><strong>Size 22:</strong> Used for skin incisions in both cardiac and thoracic surgery and to cut the bronchus in lung resection surgery. &nbsp;&nbsp;</li>
<li><strong>Size 24:</strong> Used for corner cuts, trimming, stripping and cutting mats and gaskets.</li>
</ul>
</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 22</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong> </strong> <strong>Identify the x-ray image:</strong></p>
<p><strong><img title="image053.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/eb93b156-1e6d-4e6b-8c4b-6ae6b6818aab.jpg" alt="" width="202" height="185" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Pneumothorax</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Tetralogy of fallot</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Flail chest</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Hiatal hernia</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li><strong>Pneumothorax:</strong> Air in pleural space</li>
<li>Pneumothorax is defined as the presence of air or gas in the pleural cavity, which can impair oxygenation and/or ventilation.</li>
<li>A pneumothorax should result in hyper resonance of the affected side. Atelectasis on the right side would shift the trachea to the right.</li>
<li>The most characteristic findings of pneumothorax are hyper-resonance and decreased breath sounds.</li>
<li>Occasionally hyper expansion of the ipsilateral chest or subcutaneous emphysema may occur.</li>
<li>A tension pneumothorax may displace the mediastinum and trachea to the unaffected side.</li>
<li>Tactile fremitus would be decreased in the patient with a pneumothorax; increased fremitus suggests lung consolidation.</li>
<li>Neither rales (suggesting alveolar fluid) nor a localized wheeze (suggesting airway narrowing) would be anticipated in pneumothorax.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 23</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Identify the given condition in the image:</strong></p>
<p><strong><img title="image055.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/6ae453d2-70dc-4e7c-8dc2-e62b3f8c2d6c.jpg" alt="" width="173" height="206" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Omphalocele</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Gangrenous colon</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Crohn&rsquo;s disease</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Abdominal hernia</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Bowel infarction or gangrenous bowel represents an irreversible injury to the intestine resulting from insufficient blood flow. It is considered a medical emergency because it can quickly result in life-threatening infection and death.</li>
<li>If blood flow to your intestine is completely and suddenly blocked, intestinal tissue can die (gangrene) &rarr; Perforation: A hole through the wall of the intestines can develop &rarr; This results in the contents of the intestine leaking into the abdominal cavity, causing a serious infection (peritonitis).</li>
<li>Omphalocele, also known as exomphalos, is a birth defect of the abdominal (belly) wall. The infant's intestines, liver or other organs stick outside of the belly through the belly button. The organs are covered in a thin, nearly transparent sac that hardly ever is open or broken.</li>
<li>A hernia occurs when an organ pushes through an opening in the muscle or tissue that holds it in place. For example, the intestines may break through a weakened area in the abdominal wall. Many hernias occur in the abdomen between your chest and hips, but they can also appear in the upper thigh and groin areas. Abdominal hernias are common and not necessarily dangerous.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 24</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>What is the size of IV cannula shown in the image?</strong></p>
<p><strong><img title="image056.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/08a34b75-f28f-41e0-8884-a97b7c35fec7.jpg" alt="" width="179" height="134" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>18G</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>20G</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>22G</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>24G</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Color-Coding of IV cannulas</strong></p>
<p><strong><img src="data:image/jpeg;base64,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" width="353" height="145" /></strong></p>
<p><strong>Figure:</strong> Commonly used IV cannula</p>
<p><strong>Table:</strong> Color Coding of IV Cannula</p>
<p><img title="Screenshot 2025-02-03 172830.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/2002ffff-1ae7-403f-9251-a88a7e7f00a0.png" alt="" width="400" height="278" /></p>
<p><img title="Screenshot 2025-02-03 172914.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/130847d4-191a-4e21-8ee6-86aa4419a705.png" alt="" width="400" height="476" /></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 25</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Identify the pulse site in the image:</strong></p>
<p><strong><img title="image060.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/b1788120-4b05-46f0-95f7-6a5dac5f3fc9.jpg" alt="" width="195" height="139" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Carotid</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Occipital</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Temporal</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Popliteal</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li><strong>Temporal pulse -</strong> The temporal pulse (i.e. superficial temporal artery) is palpated on the temple directly in front of the ear with the index finger.</li>
<li><strong>Carotid artery pulse -</strong> The common carotid artery is palpated on the neck below the jaw and lateral to the larynx/trachea (i.e. mid-point between your earlobe and chin) using the middle and index fingers.</li>
<li><strong>Brachial artery pulse -</strong> The brachial artery is palpated on the anterior aspect of the elbow by gently pressing the artery against the underlying bone with the middle and index fingers. The brachial artery pulse is commonly used to measure blood pressure with a stethoscope and sphygmomanometer.</li>
<li><strong>Radial artery pulse -</strong> The radial pulse is palpated immediately above the wrist joint near the base of the thumb (i.e. common site) or in the anatomical snuff box (i.e. alternative site), by gently pressing the radial artery against the underlying bone with the middle and index fingers.</li>
<li><strong>Femoral pulse -</strong> The femoral pulse is palpated over the ventral thigh between the pubic symphysis and anterior superior iliac spine with the middle and index fingers.</li>
<li><strong>Popliteal pulse -</strong> The popliteal pulse is palpated on the posterior knee with the middle and index fingers; this pulse is more difficult to palpate as compared to other pulse sites.</li>
<li><strong>Posterior tibial pulse -</strong> The posterior tibial pulse is palpated posterior and inferior to the medial malleolus by gently pressing the tibial artery against the underlying bone with the middle and index fingers.</li>
<li><strong>Dorsalis pedis pulse -</strong> The dorsalis pedis pulse is palpated in the groove between the first and second toes slightly medial on the dorsum of the foot (i.e. dorsal-lateral to the extensor hallucis longus tendon and distal to the dorsal prominence of the navicular bone) with the middle and/or index fingers.</li>
<li><strong>Apical pulse -</strong> The unilateral apical pulse (i.e. apex of the heart) can be located in the fifth intercostal space immediately to the left of the sternum using a stethoscope. In contrast to other pulses, the apical pulse is measured over the heart and not an artery and is commonly heard with a stethoscope as opposed to palpated.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 26</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>What is the normal neonatal heart rate? &nbsp;</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>120 - 160 BPM</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>100 - 120 BPM</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>160 - 200 BPM</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>80 - 100 BPM</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li><strong>For resting heart rate:</strong>
<ul style="list-style-type: circle;">
<li>Newborns 0 to 1 month old: 70 to 190 beats per minute.</li>
<li>Infants 1 to 11 months old: 80 to 160 beats per minute.</li>
<li>Children 1 to 2 years old: 80 to 130 beats per minute.</li>
</ul>
</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 27</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The needle in the image is used for:</strong></p>
<p><strong><img title="image062.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/d1c4a7e0-d4e7-4f2f-b101-95383429a302.jpg" alt="" width="136" height="177" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Bone marrow biopsy</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Laparoscopic procedure</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Lumbar puncture</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Blood sampling</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>The M&ouml;lnlycke Veress Needle is used to create a pneumoperitoneum in laparoscopic procedures.</li>
<li>It incorporates a retracting spring loaded blunt stylet and sharp hollow bore needle.</li>
<li>It is used to establish pneumoperitoneum prior to trocar and cannula insertion in laparoscopic procedures.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 28</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following is the first discovered vaccine? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Chicken Pox</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Rabies</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Small pox</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>H1N1 Flue</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Edward Jenner is considered the founder of vaccinology in the West in 1796, after he inoculated a 13 year-old-boy with vaccinia virus (cowpox) and demonstrated immunity to smallpox. In 1798, the first smallpox vaccine was developed.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 29</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following vitamin deficiency will cause pernicious anemia?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Vitamin B<sub>12</sub></p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Folic acid deficiency</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Serum Iron deficiency</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Calcium deficiency</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>The most common malabsorption disease is pernicious anemia, in which there is a lack of gastric intrinsic factor, a carrier protein essential for vitamin B12 absorption in the terminal small bowel.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 30</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Corona virus has spread worldwide. This is known as: </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Epidemic</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Pandemic</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Zoonotic</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Endemic</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Pandemic:</strong></p>
<ul>
<li>A pandemic is a disease outbreak that spreads across countries or continents.</li>
<li>It affects more people and takes more lives than an epidemic.</li>
<li>The World Health Organization (WHO) declared COVID-19 to be a pandemic when it became clear that the illness was severe and that it was spreading quickly over a wide area.</li>
</ul>
<p><strong>Endemic:</strong></p>
<ul>
<li>Constant presence of a disease or infectious agent in a defined geographical area.</li>
<li>It is the usual or expected frequency of a disease in a population.</li>
</ul>
<p><strong>Epidemic:</strong></p>
<ul>
<li>Single exposure or point source epidemics: All cases develop within one incubation period.</li>
<li>Continuous or repeated exposure epidemics: Secondary waves or Peaks.</li>
<li>Propagated epidemics: Results from person to person transmission.</li>
</ul>
<p><strong>Sporadic:</strong></p>
<ul>
<li>Cases which are &ldquo;Scattered about&rdquo;.</li>
<li>Cases are widely separated in space and time.</li>
<li>There is no recognizable source of infection.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 31</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following is incorrect about bed sore?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Mobilization will affect bed sore</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Moisture will affect bed sore</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Friction force will affect bed sore</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Nutritional status does not affect bedsore</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Bedsores can happen when a person is bedridden or otherwise immobile, unconscious or unable to sense pain.</li>
<li>Bedsores are ulcers that happen on areas of the skin that are under pressure from lying in bed, sitting in a wheelchair or wearing a cast for a prolonged time.</li>
<li>Pressure score occurs if external pressure exceeds 30 mmHg of capillary occlusive pressure.</li>
<li>Tissue necrosis with prolonged pressure.</li>
<li>It is also known as bed sores, pressure ulcers, decubitus ulcers.</li>
<li>Incidence: 5% in hospitalized patient.</li>
<li><strong>Pressure sore is most common in: Ischium &gt; Greater trochanter &gt; Sacrum in the gluteal region</strong>.</li>
<li>After Gluteal region the site in order are: Heel &gt; Lateral malleoli &gt; occipital region.</li>
</ul>
<p><strong>Table: Classification of Pressure Sores</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 8.69231%;" width="66">
<p><strong>Stage </strong></p>
</td>
<td style="width: 20.8462%;" width="156">
<p><strong>&nbsp;Description </strong></p>
</td>
<td style="width: 32%;" width="240">
<p><strong>&nbsp; &nbsp;Cause </strong></p>
</td>
<td style="width: 38.3846%;" width="288">
<p><strong>&nbsp; Management </strong></p>
</td>
</tr>
<tr>
<td style="width: 8.69231%;" width="66">
<p><strong>1</strong></p>
</td>
<td style="width: 20.8462%;" width="156">
<p>Non-blanchable erythema without a breach in the epidermis</p>
</td>
<td style="width: 32%;" width="240">
<ul>
<li>If the cause is direct pressure then either ensure that the patient&rsquo;s position is changed more frequently or &lsquo;step-up&rsquo; the pressure relief, e.g. move the patient from a static foam mattress to an alternating pressure mattress.</li>
</ul>
</td>
<td style="width: 38.3846%;" width="288">
<ul>
<li>The skin in a grade 1 pressure ulcer is not broken but it requires protection and monitoring.</li>
<li>Wound dressings for a grade 1 pressure ulcer should be simple (Dressing should not be done for stage 1 as skin is intact) and offer protection without risking any further skin damage, especially if the patient is sliding down the bed or chair causing the dressing to &lsquo;ruck&rsquo;.</li>
<li>A film dressing or a thin hydrocolloid would be appropriate to protect the wound area.</li>
<li>The slippery nature of these dressings may reduce further friction or shearing if these factors are involved.</li>
</ul>
</td>
</tr>
<tr>
<td style="width: 8.69231%;" width="66">
<p><strong>2</strong></p>
</td>
<td style="width: 20.8462%;" width="156">
<p>Partial-thickness skin loss involving the epidermis and dermis</p>
</td>
<td style="width: 32%;" width="240">
<ul>
<li>If the pressure ulcer is circular, this is often an indication that direct pressure is the cause. In this case ensure that the patient&rsquo;s position is changed more frequently or &lsquo;step-up&rsquo; the level of pressure relief.</li>
<li>If the pressure ulcer is not uniform and is more widespread, then shearing or friction may be the cause.</li>
</ul>
</td>
<td style="width: 38.3846%;" width="288">
<ul>
<li>A grade 2 pressure ulcer is a superficial wound. If the wound has slough on the wound bed, <strong>debridement </strong>may be necessary.</li>
<li>There are many dressings that aid debridement, for example, hydrogels or hydrocolloids.</li>
<li>If protection is necessary as well as the promotion of a moist wound healing environment, a hydrocolloid or foam may be appropriate.</li>
<li>Dressing some areas may be a challenge like in sacral and heel region. So sacral flap also used.</li>
</ul>
</td>
</tr>
<tr>
<td style="width: 8.69231%;" width="66">
<p><strong>3</strong></p>
</td>
<td style="width: 20.8462%;" width="156">
<p>Full-thickness skin loss extending into the subcutaneous tissue but not through underlying fascia</p>
</td>
<td style="width: 32%;" width="240">
<ul>
<li>The damaging factors (pressure, shear or friction) are continuing.</li>
<li>The dressings are not managing the exudate levels and the wound is getting bigger or deeper due to the destructive nature of chronic exudate</li>
<li>The pressure ulcer may be infected</li>
<li>The patient has a poor ability to heal, which may be due to poor circulation, inadequate nutrition, low hemoglobin levels or the presence of disease such as diabetes mellitus.</li>
</ul>
</td>
<td style="width: 38.3846%;" width="288">
<ul>
<li>&nbsp;As these pressure ulcers are substantially deep in many cases, the <strong>absorbency levels of the dressings may need to be increased</strong>.</li>
<li><strong>Alginates and Foams absorbent dressings</strong> can be used in combination to increase the overall absorbency.</li>
<li>If this is occurring after the absorbent dressings, <strong>increase the dressing absorbency levels or the frequency of dressing</strong> changes.</li>
<li>If conventional dressings cannot manage the exudate, <strong>topical negative pressure therapy</strong> could be considered.</li>
</ul>
</td>
</tr>
<tr>
<td style="width: 8.69231%;" width="66">
<p><strong>4</strong></p>
</td>
<td style="width: 20.8462%;" width="156">
<p>Full-thickness skin loss through fascia with extensive tissue destruction, may be involving muscles, one, tendon or joint.</p>
</td>
<td style="width: 32%;" width="240">
<ul>
<li>Grade 4 pressure ulcers are the deepest. It is essential to establish if or why the wound is deteriorating or if the depth of the wound is due to the initial pressure damage.</li>
</ul>
</td>
<td style="width: 38.3846%;" width="288">
<ul>
<li>The steps outlined under the <strong>treatment of grade 3</strong> pressure ulcers should be followed.</li>
<li>If there is bone exposed, consider infection in the bone (osteomyelitis). This can be identified using an X-ray or a magnetic resonance imaging (MRI) scans and is usually treatable with <strong>antibiotic therapy</strong>.</li>
</ul>
</td>
</tr>
</tbody>
</table>
<p><img title="image063.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/c4d54219-8a1a-4fdd-872f-79bcce887c68.jpg" alt="" width="400" height="131" /></p>
<p>&nbsp;&nbsp;&nbsp;&nbsp; <strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Figure 1:</strong> Pressure score grading</p>
<p><img title="image065.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/3aab2db0-bdf0-498f-8183-5f90bb838724.jpg" alt="" width="450" height="125" /></p>
<p><strong>Figure 2:</strong> Pressure score grading</p>
<ul>
<li><strong>Prevention is the best treatment</strong></li>
<li>Bedridden patients turned every 2 hours</li>
<li>Wheel chair patient lift themselves every 10 minutes for 10 seconds</li>
<li>Provide air mattress bedding</li>
<li><strong>Treatment</strong></li>
<li>Debridement</li>
<li>VAC devices at negative -<strong>125 mm Hg suction pressure </strong></li>
<li>Flaps</li>
</ul>
<p><img title="image004.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/d70d39cd-851a-4554-8daa-c65d9fb96469.jpg" alt="" width="226" height="175" /></p>
<p><strong>Figure 3: </strong>Sacral dressing</p>
<p><strong>Clinical Pearls: </strong></p>
<ul>
<li>During dressing for pressure ulcers: Keep the ulcer tissue moist and surrounding skin dry.</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 32</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following drug is contraindicated in pregnant lady?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Heparin</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Labetalol</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Dolutegravir</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Streptomycin</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Streptomycin can cause fetal harm when administered to a pregnant woman. Because streptomycin readily crosses the placental barrier, caution in use of the drug is important to prevent ototoxicity in the fetus.</li>
<li>Heparin is indicated in pregnancy till 34 weeks&rsquo;.</li>
<li>Labetalol is indicated in Pregnancy induced Hypertension.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 33</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Lorazepam challenging test is done to validate the diagnosis of &hellip;&hellip;&hellip;.:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Catatonia</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Stupor</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Dementia</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Depression</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Lorazepam challenge test (LCT) is widely used to either confirm a catatonia diagnosis or determine lorazepam sensitivity. It has a proposed schedule for administering lorazepam</li>
<li>A positive Lorazepam Challenge Test validates the diagnosis of catatonia. After the patient is examined for signs of catatonia, 1 or 2 mg of lorazepam is administered intravenously. After 5 minutes, the patient is re-examined.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 34</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Identify the image:</strong></p>
<p><strong><img title="image068.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/4bbb147f-6191-426d-976a-45a1c7f7079e.png" alt="" width="159" height="159" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Linear stapler</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Punch biopsy</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Bone marrow needle</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Trocar</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Linear stapler </strong></p>
<p><img title="1.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/0ade8a99-1c6c-47c5-b6c6-00ed378a46d6.png" alt="" width="214" height="120" /></p>
<p><strong>Figure 1: </strong>Linear Stapler</p>
<ul>
<li>Used for side to side anastomosis of bowel as in gastro jejunostomy.</li>
</ul>
<p><strong>Circular stapler </strong></p>
<p><strong><img title="2.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/7d65534f-b74c-4a7e-afe0-9e790305c133.png" alt="" width="236" height="98" /></strong></p>
<p><strong>Figure 2: </strong>Circular Stapler</p>
<ul>
<li>Used to do end to end anastomosis of bowels in anterior resection, Esophago-jejunal anastomosis.</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 35</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Identify the image:</strong></p>
<p><strong><img title="Screenshot 2025-02-03 173840.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/6ef8b105-0dd9-43a4-8a09-c4435e003888.png" alt="" width="272" height="165" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Circular stapler</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Vein viewer</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Biopsy gun</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Trocar</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Linear stapler</strong></p>
<p><strong><img title="3.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/a89fc635-54cd-49cb-84e0-a7653157d4da.png" alt="" width="293" height="164" />&nbsp;</strong></p>
<p><strong>Figure 1: </strong>Linear Stapler</p>
<ul>
<li>Used for side to side anastomosis of bowel as in gastro jejunostomy.</li>
</ul>
<p><strong>Circular stapler</strong></p>
<p><strong>&nbsp;<img title="4.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/7e4aacfc-a07f-448e-b2bc-f3a7dd31f504.png" alt="" width="292" height="121" /></strong></p>
<p><strong>Figure 2: </strong>Circular Stapler</p>
<ul>
<li>Used to do end to end anastomosis of bowels in anterior resection, esophago-jejunal anastomosis.</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 36</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Diagnostic test used for DIC:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>PT</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>INR</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>PT, aPTT</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>DCT, ICT</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li><strong>In (Disseminated intravascular coagulation (DIC))</strong>, there is consumption of fibrinogen; factors II, V and VIII; and platelets. Therefore, there is prolongation of PT, aPTT and TT and a decrease in factor VIII level and platelet count. In addition, the titer of fibrin split production is usually increased. D-dimer is a fibrin breakdown product and may also be elevated in DIC.</li>
<li>The prolongation of PT, aPTT and TT excludes the diagnosis of ITP.</li>
<li>PT tests principally for factors I, II, V, VII and X and is not prolonged in hemophilia A (factor VIII deficiency) or hemophilia B (factor IX deficiency).</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 37</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Antimicrobial dressing is composed of which of the following metal?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Copper</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Zinc</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Sodium</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Silver</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Antimicrobial dressings are applied topically to the wound where they exert a broad spectrum of non-selective antibacterial action. They act at multiple sites within microbial cells, thus reducing the likelihood of bacteria developing resistance.</li>
<li>An absorbent, non-woven, silver-containing antimicrobial dressing composed of cellulose ethyl sulphonate fibers.</li>
<li>An absorbent, non-woven, silver containing antimicrobial dressing composed of cellulose ethyl sulphonate fibers.</li>
<li>Antimicrobial dressing is used for: Spreading infection at the wound site requires treatment with systemic antibacterial. For local wound infection, a topical antimicrobial dressing can be used to reduce the level of bacteria at the wound surface but will not eliminate a spreading infection.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 38</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which among the following is added to ORS to control diarrhea? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Copper</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Calcium</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Zinc</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Potassium</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Vitamin A and zinc are supplemented as both of them enhance the recovery from persistent diarrhea.</li>
<li>A single dose of vitamin A at 2,00,000 IU for children &gt;12 months or 1,00,000 IU for children 6 - 12 months or children weighing less than 8 kg, irrespective of age, should be given.</li>
<li>10 - 20 mg per day of elemental zinc for at least 2 weeks should be given to children between 6 months and 3 year of age.</li>
</ul>
<p><strong>Table: Comparison between WHO Universal and Reduced Osmolality ORS</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 24.9231%;" width="183">
<p>&nbsp;</p>
</td>
<td style="width: 24.9231%;" width="183">
<p><strong>WHO UNICEF ORS(All values in mmol/liter)</strong></p>
</td>
<td style="width: 24.9231%;" width="183">
<p><strong>Reduced Osmolality ORS (A values in mmol/liter)</strong></p>
</td>
<td style="width: 25.0769%;" width="183">
<p><strong>ReSoMal (All values in mmol/ liter)</strong></p>
</td>
</tr>
<tr>
<td style="width: 24.9231%;" width="183">
<p>Sodium</p>
</td>
<td style="width: 24.9231%;" width="183">
<p>90</p>
</td>
<td style="width: 24.9231%;" width="183">
<p>75</p>
</td>
<td style="width: 25.0769%;" width="183">
<p>45</p>
</td>
</tr>
<tr>
<td style="width: 24.9231%;" width="183">
<p>Chloride</p>
</td>
<td style="width: 24.9231%;" width="183">
<p>80</p>
</td>
<td style="width: 24.9231%;" width="183">
<p>65</p>
</td>
<td style="width: 25.0769%;" width="183">
<p>70</p>
</td>
</tr>
<tr>
<td style="width: 24.9231%;" width="183">
<p>Glucose</p>
</td>
<td style="width: 24.9231%;" width="183">
<p>111</p>
</td>
<td style="width: 24.9231%;" width="183">
<p>75</p>
</td>
<td style="width: 25.0769%;" width="183">
<p>125</p>
</td>
</tr>
<tr>
<td style="width: 24.9231%;" width="183">
<p>Potassium</p>
</td>
<td style="width: 24.9231%;" width="183">
<p>20</p>
</td>
<td style="width: 24.9231%;" width="183">
<p>20</p>
</td>
<td style="width: 25.0769%;" width="183">
<p>40</p>
</td>
</tr>
<tr>
<td style="width: 24.9231%;" width="183">
<p>Citrate</p>
</td>
<td style="width: 24.9231%;" width="183">
<p>10</p>
</td>
<td style="width: 24.9231%;" width="183">
<p>10</p>
</td>
<td style="width: 25.0769%;" width="183">
<p>7</p>
</td>
</tr>
<tr>
<td style="width: 24.9231%;" width="183">
<p>Magnesium</p>
</td>
<td style="width: 24.9231%;" width="183">
<p>---</p>
</td>
<td style="width: 24.9231%;" width="183">
<p>----</p>
</td>
<td style="width: 25.0769%;" width="183">
<p>3</p>
</td>
</tr>
<tr>
<td style="width: 24.9231%;" width="183">
<p>Zinc</p>
</td>
<td style="width: 24.9231%;" width="183">
<p>---</p>
</td>
<td style="width: 24.9231%;" width="183">
<p>----</p>
</td>
<td style="width: 25.0769%;" width="183">
<p>0.3</p>
</td>
</tr>
<tr>
<td style="width: 24.9231%;" width="183">
<p>Copper</p>
</td>
<td style="width: 24.9231%;" width="183">
<p>&nbsp;</p>
</td>
<td style="width: 24.9231%;" width="183">
<p>&nbsp;</p>
</td>
<td style="width: 25.0769%;" width="183">
<p>0.45</p>
</td>
</tr>
<tr>
<td style="width: 24.9231%;" width="183">
<p>Total osmolality</p>
</td>
<td style="width: 24.9231%;" width="183">
<p>311</p>
</td>
<td style="width: 24.9231%;" width="183">
<p>245</p>
</td>
<td style="width: 25.0769%;" width="183">
<p>&nbsp;</p>
</td>
</tr>
</tbody>
</table>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 39</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Identify the image given below</strong><strong>:</strong><strong>&nbsp;</strong></p>
<p><strong><img title="image077.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/f3a6e7b2-7d8f-4a44-8b88-faaa865b9684.jpg" alt="" width="232" height="146" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Monopolar cautery</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Bipolar cautery</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Harmonic scalpel</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Surgical scalpel</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Table: Types of Cautery </strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 14.4615%;" width="110">
<p><strong>Features</strong></p>
</td>
<td style="width: 41.8462%;" width="317">
<p><strong>&nbsp; &nbsp;Monopolar</strong></p>
</td>
<td style="width: 43.6154%;" width="330">
<p><strong>Bipolar</strong></p>
</td>
</tr>
<tr>
<td style="width: 14.4615%;" width="110">
<p>Flow of current</p>
</td>
<td style="width: 41.8462%;" width="317">
<p>Cautery pencil &rarr; Tissue &rarr; Cautery pad &rarr; Machine/ground</p>
<p>Hence more chance of burn.</p>
</td>
<td style="width: 43.6154%;" width="330">
<p>Only between tips of the instrument</p>
<p>Hence less chance of burn</p>
</td>
</tr>
<tr>
<td style="width: 14.4615%;" width="110">
<p>Modes</p>
</td>
<td style="width: 41.8462%;" width="317">
<ul>
<li><strong>Coagulation:</strong> Alternate waveforms (Bursts)</li>
<li><strong>Desiccation:</strong> Low power</li>
<li><strong>Fulguration:</strong> High power</li>
</ul>
</td>
<td style="width: 43.6154%;" width="330">
<p>Only coagulation</p>
</td>
</tr>
<tr>
<td style="width: 14.4615%;" width="110">
<p>Dissipation</p>
</td>
<td style="width: 41.8462%;" width="317">
<ul>
<li>More thermal dissipation current.</li>
<li>Hence can cause damage to nerves and other vital structures.</li>
</ul>
</td>
<td style="width: 43.6154%;" width="330">
<ul>
<li>Less lateral dissipation current.</li>
<li>Hence safer in procedures to vital structures.</li>
</ul>
</td>
</tr>
<tr>
<td style="width: 14.4615%;" width="110">
<p>Image</p>
</td>
<td style="width: 41.8462%;" width="317">
<p><img src="data:image/jpeg;base64,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" width="226" height="138" /></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
</td>
<td style="width: 43.6154%;" width="330"><img title="image080.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/92226189-5a62-4474-bab2-cb5447e8895e.jpg" alt="" width="200" height="189" /></td>
</tr>
</tbody>
</table>
<p><strong>Harmonic scalpel</strong></p>
<p><strong><img title="image082.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/1db43f89-515d-426b-a9ce-4483621d11fd.png" alt="" width="300" height="225" /></strong></p>
<p><strong>Figure: </strong>Harmonic Scalpel</p>
<ul>
<li>It can cause coagulation without heat production.</li>
<li>It works on the ultrasonic principle.</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 40</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which hormone regulates calcium and phosphate?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Parathyroid Hormone</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Calcitonin</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Thyroid Hormone</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>LH</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Parathyroid hormone regulates calcium levels in the blood, largely by increasing the levels when they are too low.</li>
<li>It does this through its actions on the kidneys, bones and intestine: Bones &ndash; parathyroid hormone stimulates the release of calcium from large calcium stores in the bones into the bloodstream.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 41</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A t</strong><strong>o or between</strong><strong>&nbsp;which week</strong><strong>s</strong><strong>,</strong><strong>&nbsp;mother feels movement of the baby</strong><strong>?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>10 - 12 Weeks</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>12 - 14 Weeks</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>14 - 16 Weeks</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>18 - 20 Weeks</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Quickening (feeling of life) denotes the perception of active fetal movements by the women. It is usually felt about the 18<sup>th</sup> week, 2 weeks earlier in multiparae. Its appearance is a useful guide to calculate the expected date of delivery with reasonable accuracy&rdquo;</li>
<li>Quickening is felt between 16<sup>th</sup> to 20<sup>th</sup></li>
</ul>
<p>&nbsp;<strong>Table: Timings of Phenomenon During Pregnancy</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 49.9231%;" width="367">
<p><strong>Phenomenon</strong></p>
</td>
<td style="width: 50%;" width="367">
<p><strong>Time</strong></p>
</td>
</tr>
<tr>
<td style="width: 49.9231%;" width="367">
<p>Palpation of fetal part</p>
</td>
<td style="width: 50%;" width="367">
<p>20 weeks&rsquo;</p>
</td>
</tr>
<tr>
<td style="width: 49.9231%;" width="367">
<p>Active fetal movement felt by placing a hand on abdomen</p>
</td>
<td style="width: 50%;" width="367">
<p>20 weeks&rsquo;</p>
</td>
</tr>
<tr>
<td style="width: 49.9231%;" width="367">
<p>External Ballottement</p>
</td>
<td style="width: 50%;" width="367">
<p>20 weeks&rsquo;</p>
</td>
</tr>
<tr>
<td style="width: 49.9231%;" width="367">
<p>Internal Ballottement</p>
</td>
<td style="width: 50%;" width="367">
<p>16 - 28 weeks&rsquo;</p>
</td>
</tr>
<tr>
<td style="width: 49.9231%;" width="367">
<p>FHS audible by Stethoscope</p>
</td>
<td style="width: 50%;" width="367">
<p>18 - 20 weeks&rsquo;</p>
</td>
</tr>
<tr>
<td style="width: 49.9231%;" width="367">
<p>Fetal movement can be detected by Doppler</p>
</td>
<td style="width: 50%;" width="367">
<p>10 weeks&rsquo;</p>
</td>
</tr>
<tr>
<td style="width: 49.9231%;" width="367">
<p>Lightening</p>
</td>
<td style="width: 50%;" width="367">
<p>38 weeks&rsquo;</p>
</td>
</tr>
</tbody>
</table>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 42</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which electrolyte causes atrial depolarization?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Sodium</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Potassium</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Calcium</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Phosphate</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li><strong><strong>Sodium (Na)</strong></strong>: Sodium is crucial for initiating depolarization in cardiac cells, including those in the atria. When sodium channels open, sodium ions rapidly enter the cells, causinga change in membrane potential that leads to atrial depolarization and the propagation of action potentials, which ultimately triggers heart contractions.</li>
<li><strong><strong>Potassium (K)</strong></strong>: Potassium is primarily involved in repolarization of the cardiac cells after depo It helps restore the resting membrane potential by exiting the cells. An imbalance in potassium levels can lead to arrhythmias, but it is not responsible for the initial depolarization.</li>
<li><strong><strong>Calcium (Ca&sup2;)</strong></strong>: Calcium plays a significant role in cardiac muscle contraction. During the action potential, calcium ions enter the cells through calcium channels after depolarization occurs. This influx of calcium triggers the contraction of the muscle fibers, but it is not the primary cause of atrial depolarization itself.</li>
<li><strong><strong>Phosphate (HPO&sup2;)</strong></strong>: Phosphate does not play a direct role in cardiac depolarization or contraction. It is more involved in cellular energy metabolism and the formation of ATP, rather than in the electrical activity of the heart.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 43</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Identify the pelvic gr</strong><strong>ip shown in the image</strong><strong>:</strong></p>
<p><strong><img title="image084.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/457a27c6-bd82-4632-8785-d882ff2bab55.jpg" alt="" width="313" height="204" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Fundal grip</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Lateral grip</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Pawlick grip</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Deep pelvic grip</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Table: Leopold Maneuvers: </strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 12.7692%;" width="97">
<p><strong>Leopold </strong></p>
</td>
<td style="width: 23%;" width="174">
<p><strong>Grip</strong></p>
</td>
<td style="width: 64.1538%;" width="486">
<p><strong>Importance</strong></p>
</td>
</tr>
<tr>
<td style="width: 12.7692%;" width="97">
<p>First</p>
</td>
<td style="width: 23%;" width="174">
<p>Fundal</p>
</td>
<td style="width: 64.1538%;" width="486">
<p>To know which fetal pole occupied the uterine fundus</p>
</td>
</tr>
<tr>
<td style="width: 12.7692%;" width="97">
<p>Second</p>
</td>
<td style="width: 23%;" width="174">
<p>Lateral/Umbilical</p>
</td>
<td style="width: 64.1538%;" width="486">
<p>To know the fetal back and extremities</p>
</td>
</tr>
<tr>
<td style="width: 12.7692%;" width="97">
<p>Third</p>
</td>
<td style="width: 23%;" width="174">
<p>Pawlick</p>
</td>
<td style="width: 64.1538%;" width="486">
<p>To know presenting fetal part in respect to the true pelvis</p>
</td>
</tr>
<tr>
<td style="width: 12.7692%;" width="97">
<p>Fourth</p>
</td>
<td style="width: 23%;" width="174">
<p>Pelvic</p>
</td>
<td style="width: 64.1538%;" width="486">
<p>If the presenting part has already descended into the pelvis-this is not possible anymore</p>
</td>
</tr>
</tbody>
</table>
<p><img title="image086.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/803375f5-cf25-47c2-89ad-3da31b6d9345.png" alt="" width="407" height="383" /></p>
<p><strong>Figure: </strong>Leopold Maneuver</p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 44</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Blue color pipelines in OT is used to deliver</strong><strong>:</strong></p>
<p><strong><img title="Picture 02.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/8e9dc602-1b6f-4af4-ab89-588bcfe58625.png" alt="" width="250" height="125" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Oxygen</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Medical air</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Vacuum</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Nitrous oxide</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li><strong>Nitrous oxide</strong> is used via an anesthesia machine; it gets mixed with oxygen and other gases while operating. Due to its purpose, nitrous oxide outlets are always put only in operation theatres. Cylinders and pipeline of Nitrous oxide are always denoted by Blue color.</li>
</ul>
<p><strong>Table: </strong>Color Coding of Medical Gas Cylinders</p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 43.6923%;" width="252">
<p><strong>Medical Gas</strong></p>
</td>
<td style="width: 56.2308%;" width="324">
<p><strong>Color</strong></p>
</td>
</tr>
<tr>
<td style="width: 43.6923%;" width="252">
<p>Oxygen</p>
</td>
<td style="width: 56.2308%;" width="324">
<p>White</p>
</td>
</tr>
<tr>
<td style="width: 43.6923%;" width="252">
<p>Nitrous oxide</p>
</td>
<td style="width: 56.2308%;" width="324">
<p>Blue</p>
</td>
</tr>
<tr>
<td style="width: 43.6923%;" width="252">
<p>Medical air</p>
</td>
<td style="width: 56.2308%;" width="324">
<p>White and Black stripes</p>
</td>
</tr>
<tr>
<td style="width: 43.6923%;" width="252">
<p>Carbon dioxide</p>
</td>
<td style="width: 56.2308%;" width="324">
<p>Grey</p>
</td>
</tr>
</tbody>
</table>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 45</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Pain in the Mc Burney&rsquo;s point is </strong><strong>feature </strong><strong>of</strong><strong>:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Cholelithiasis</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Appendicitis</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Urolithiasis</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Nephrolithiasis</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Pain over McBurney's point, the point halfway between the umbilicus and the iliac crest, is diagnosis for appendicitis.</li>
<li>McBurney&rsquo;s point is defined as a point that lies one-third of the distance laterally on a line drawn from the umbilicus to the right anterior superior iliac spine. Classically, it corresponds to the location of the base of the appendix</li>
</ul>
<p><img title="Picture03.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/e4a85b2c-a37e-4190-8154-ade517a0153a.png" alt="" width="345" height="242" /></p>
<p><strong>Fig</strong><strong>ure</strong><strong>: </strong>McBurney's point</p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 46</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Surgical glove will be discarded in which color </strong><strong>of </strong><strong>biomedical bag</strong><strong>?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Yellow</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Block</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Green</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Red</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Biomedical Waste Management </strong></p>
<p><strong>Yellow Bag </strong></p>
<p><img title="image040.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/9838980d-ef6a-4af8-93b9-6bd63c853a99.jpg" alt="" width="146" height="149" /></p>
<p><strong>Figure 1: </strong>Yellow Bag</p>
<ul>
<li><strong>Human </strong><strong>a</strong><strong>natomical </strong><strong>waste:</strong>Human tissue&nbsp;organs, body parts&nbsp;and&nbsp;fetus.&nbsp;</li>
<li><strong>Animal waste:</strong>Animal tissues, body parts&nbsp;organs, carcasses, fluids&nbsp;and&nbsp;blood.</li>
<li><strong>Soiled </strong><strong>w</strong><strong>aste</strong><strong>:</strong>Items contaminated with blood&nbsp;and&nbsp;fluids, including cotton, dressings, soiled plaster casts, linen&nbsp;and&nbsp;&nbsp;</li>
<li><strong>Discarded </strong><strong>medicine and cytotoxic d</strong><strong>r</strong><strong>ugs</strong><strong>:</strong>Outdated contaminated and discarded drugs.</li>
<li><strong>Chemical </strong><strong>w</strong><strong>aste</strong><strong>:</strong>Chemical used in disinfection (insecticides) or in production of biological.&nbsp;</li>
<li><strong>Chemical </strong><strong>l</strong><strong>iquid </strong><strong>w</strong><strong>aste</strong><strong>:</strong>Waste generated from lab and washing cleaning housekeeping and disinfecting activities.</li>
<li><strong>Microbiology and </strong><strong>biotechnology waste</strong><strong>:</strong>Waste from lab cultures, stocks, specimens of microorganisms, live or attenuated vaccine, cell cultures (Human/Animal), wastes from production of biological, toxins.&nbsp;</li>
</ul>
<p><strong>&nbsp;</strong><strong>Red Bag</strong></p>
<p><strong><img title="image041.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/f0c31e53-8986-4eb6-8634-c39197c7ea81.jpg" alt="" width="148" height="148" /></strong></p>
<p><strong>Figure 2: </strong>Red Bag&nbsp;&nbsp;&nbsp;&nbsp;</p>
<ul>
<li><strong>Contaminated waste (Recyclable):</strong>Disposable items (except sharps) including tubing, catheters, intravenous tubes and sets, urine bags, syringes (without needles and fixed needle syringes) and vacutainer with needle cut and gloves. &nbsp;</li>
</ul>
<p><strong>White Bag</strong></p>
<p><strong><img title="image042.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/e7025c33-fae2-4314-b049-5d3b7c674a8b.jpg" alt="" width="114" height="148" /></strong></p>
<p><strong>Figure 3: </strong>&nbsp;White Bag</p>
<ul>
<li><strong>Waste Sharps:</strong>Needles, Syringes, Blades, Scalpels&nbsp;and&nbsp;Glass</li>
</ul>
<p><strong>Blue Bag</strong></p>
<p><strong><img title="Picture04.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/b8118451-8e1d-4243-b65a-bfa7b65b8517.png" alt="" width="124" height="139" /></strong><strong><img title="Picture05.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/28d4f842-4c15-4695-a659-7493d3a9e20f.png" alt="" width="193" height="117" /></strong></p>
<p><strong>Figure 4: </strong>Blue Bag</p>
<ul>
<li><strong>Glassware, </strong><strong>m</strong><strong>etallic </strong><strong>Body implants:</strong>Broken or discarded and contaminated</li>
</ul>
<p><strong>Black Bag </strong></p>
<p><strong><img title="Picture06.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/ff954a0b-a074-467b-adff-2b1ce5c78fe6.png" alt="" width="139" height="150" /></strong></p>
<p><strong>Figure 5: </strong>Black Bag</p>
<ul>
<li>Wrapper of surgical syringe constitutes non-infectious waste for municipal dump&rarr;hence, discarded in black &nbsp;</li>
<li>Non-infectious wastes are disposed of in black bags (Municipal waste).</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 47</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Distended jugular vein is seen in:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Decreased CVP</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Increased CVP</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Increased Blood BP</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Decreased BP</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>When the jugular vein is visible, it's known as jugular vein distention (JVD). Internal and external jugular veins run along the right and left sides of your neck.</li>
<li>The blood flow from the head to the heart is measured by central venous pressure or CVP. Jugular vein distention or JVD is when the increased pressure of the superior vena cava causes the jugular vein to bulge, making it most visible on the right side of a person's neck.</li>
<li>Jugular vein distention may be caused by heart conditions and conditions that affect blood vessels including: Congestive heart failure (deterioration of the heart's ability to pump blood) Constrictive pericarditis (infection or inflammation of the lining that surrounds the heart that decreases the lining's flexibility).</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 48</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The assessment of acute malnutrition in children is done by:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Height</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Weight</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>BMI</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Weight for Height</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p>The nutritional indices commonly calculated for young children are:</p>
<ul>
<li>Weight for height- an index used to measure wasting or acute malnutrition; (WHAM)</li>
<li>Height for age an index used to measure stunting or chronic malnutrition; (HA-CM)</li>
<li>Weight for age - an index used to measure underweight (or wasting and stunting combined) (WASW)</li>
<li>Mid arm circumference is a specific indicator of wasting or acute malnutrition.</li>
</ul>
<p><strong>Remember</strong></p>
<ul>
<li>Weight reflects only present health status of the child whereas height indicates events in the past also.</li>
<li>Most sensitive measure of physical growth- WEIGHT.</li>
<li>Single best parameter for assessment of physical growth- WEIGHT.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 49</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Diminished lung sounds and pain during inspiration is a classical sign of:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Hemothorax</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Pneumothorax</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Pyothorax</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Chylothorax</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Pneumothorax: Air in pleural space</li>
<li>Pneumothorax is defined as the presence of air or gas in the pleural cavity, which can impair oxygenation and/or ventilation.</li>
<li>A pneumothorax should result in hyper resonance of the affected side. Atelectasis on the right side would shift the trachea to the right.</li>
<li>The most characteristic findings of pneumothorax are hyper-resonance and decreased breath sounds.</li>
<li>Occasionally hyper expansion of the ipsilateral chest or subcutaneous emphysema may occur.</li>
<li>A tension pneumothorax may displace the mediastinum and trachea to the unaffected side.</li>
<li>Tactile fremitus would be decreased in the patient with a pneumothorax; increased fremitus suggests lung consolidation.</li>
<li>Neither rales (suggesting alveolar fluid) nor a localized wheeze (suggesting airway narrowing) would be anticipated in pneumothorax.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 50</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The ET Tube size 5.5 is used for:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Infants</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Adults</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Children</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Geriatric</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Endotracheal Tube</strong></p>
<ul>
<li>A tracheal tube is a device that is inserted through the larynx into the trachea to convey gases and vapors to and from the lungs.</li>
<li>The most primitive and still the most common used airway devise is endotracheal tube.</li>
<li>Many types of ETT: Range in sizes from 3 &ndash; 9 mm in internal diameter (ID).</li>
<li>Different sizes are chosen based on the patient&rsquo;s body size and smaller sizes used for pediatric patients.</li>
<li>Tubes larger than 6 mm (internal diameter &ndash; ID) tend to have an inflatable cuff. Special double lumen ETT have been developed for lung and other inter-thoracic surgery. These tubes allow one lung ventilation while the other lung can be collapsed to make surgery easier.</li>
<li>Use 3.5 mm internal diameter cuffed endotracheal tube for children 1 to &lt;2 years of age and a 3.0 mm internal diameter cuffed endotracheal tube for children &lt;1 year of age.</li>
<li>The endotracheal tube (ETT) size formula, (age/4) + 3.5, with a cuffed tube makes more sense anatomically. Classic teaching is that we should use the formula (16+age)/4 or (age/4) + 4 to calculate the uncuffed pediatric ETT size.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 51</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following drug causes red colored urine? </strong><strong>(Pharma)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Streptomycin</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Rifampicin</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Ethambutol</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Isoniazid</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Rifampin and its metabolites may color urine, feces, saliva, sputum, sweat and tears a bright red-orange.</li>
<li>Doxorubicin IV is given to a breast cancer patient. Common side effect of doxorubicin is red color urine. Urine may appear red, red-brown orange or pink from the color of the medication for one to two days after you receive a dose.</li>
</ul>
<p><strong>Table:</strong> Color and Appearance of Urine</p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 26.8601%;" width="180">
<p><strong>Red Urine</strong></p>
</td>
<td style="width: 72.9167%;" width="487">
<p>&bull; Beet ingestion (Betacyanin excretion)</p>
<p>&bull; Phenolpthaline (in Laxatives)</p>
<p>&bull; Vegetable dye ingestion</p>
<p>&bull; Myoglobinuria</p>
<p>&bull; Hemoglobinuria</p>
<p>&bull; Seoratia Marcescens bacteria can cause the Red diaper syndrome</p>
</td>
</tr>
<tr>
<td style="width: 26.8601%;" width="180">
<p><strong>Reddish Brown/ Brown</strong></p>
</td>
<td style="width: 72.9167%;" width="487">
<p>&bull; <strong>Nitrofurantoin (Brown)</strong></p>
<p>&bull; L-Dopa</p>
<p>&bull; Alpha Methyl Dopa</p>
<p>&bull; Metronidazole</p>
</td>
</tr>
</tbody>
</table>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 52</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Lignocaine is used to treat: </strong><strong>(Pharma)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>MI</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Angina</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>CAD</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Arrhythmia</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Lignocaine injection belongs to two groups of medicines known as local anesthetics and antiarrhythmic drugs.</li>
<li>Local anesthetics stop pain and feeling in the area around which it is injected; and antiarrhythmic drugs work by restoring irregular and/or rapid heartbeats to normal.</li>
<li>Lidocaine cream is used on the skin to stop itching and pain from certain skin conditions (e.g. scrapes, minor burns, eczema, insect bites) and to treat minor discomfort and itching caused by hemorrhoids and certain other problems of the genital/anal area (e.g. anal fissures, itching around the vagina/rectum)</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 53</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>While doing suctioning if the patient develops tachycardia, what is the priority nursing action? </strong><strong>(Pharma)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Stop suction and oxygenate the patient</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Continue suction</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Inform to Physician</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Give left lateral position</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Suctioning may also stimulate the vagus nerve, triggering hypoxia and bradycardia.</li>
<li>Early warning signs of obstruction include tachypnoea, increased work of breathing, abnormal breath sounds, tachycardia and a decrease in SpO2 levels.</li>
<li>Late signs of obstruction include cyanosis, bradycardia and apnea - do not wait for these to develop before intervening.</li>
<li>Prolonged suctioning increases the risk of hypoxia and other complications. Never suction a patient for longer than 15 seconds. Rather than prolong suctioning, withdraw the catheter, re-oxygenate the patient and suction again.</li>
<li>The suction tube can be a form of airway obstruction. If the patient is not pre-oxygenated, the risk of hypoxia is high, so pre-oxygenate the patient and promptly remove the tube. If you must suction the patient multiple times, oxygenate them before each suctioning procedure.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 54</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which IV fluid will you give with packed RBC? </strong><strong>(MSN)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>3% NaCl</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>5% Dextrose</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>RL</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Normal Saline</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Normal saline is the only compatible solution to use with the blood or blood component.</li>
<li>Crystalloid solutions and medications may cause agglutination and/or hemolysis of the blood or blood components.</li>
<li>Fluid is compatible with packed red blood cells: 0.9% NaCl (normal saline), 5% Albumin and ABO-compatible plasma.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 55</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Identify the below given image: </strong><strong>(MSN)</strong></p>
<p><strong><img title="image098.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/56b5abfe-8937-4a71-b169-02b7051389a4.png" alt="" width="229" height="203" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Anesthesia trolley</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Airway cart</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Defibrillator</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Bronchoscopy trolley</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>The given above image depicts airway trolley.</li>
<li>The trolley consists of 4 drawers corresponding to Plans A, B, C and D of the Difficult Airway Society guidelines for the management of unanticipated difficult intubation.</li>
</ul>
<p><strong>Top of trolley</strong></p>
<ul>
<li>Flexible intubating fiberscope</li>
<li>Portable scope with battery light source</li>
<li>Portable stack system e.g. Storz Tele Pack</li>
<li>or single use fibrescope e.g. Ambu Scope</li>
</ul>
<p><strong>Side of trolley</strong></p>
<ul>
<li>Bougies &ndash; adult and paediatric</li>
<li>Aintree Intubation Catheter</li>
<li>Airway exchange catheter</li>
</ul>
<p><strong>Drawer 1 &ndash; Plan A</strong></p>
<ul>
<li>Bougie (ideally on side of trolley)</li>
<li>Short handle laryngoscope</li>
<li>McCoy blade and/or straight blade</li>
<li>Videolaryngoscope</li>
</ul>
<p><strong>Drawer 2 &ndash; Plan B</strong></p>
<ul>
<li>LMA #3, 4, 5 &amp;/or 2nd generation device #3, 4, 5</li>
<li>Intubating LMA (iLMA) #3, 4, 5</li>
<li>Aintree Intubating Catheter (ideally on side of trolley)</li>
<li>Fibreoptic adjuvants</li>
</ul>
<p><strong>Drawer 3 &ndash; Plan C</strong></p>
<ul>
<li>Facemasks &ndash; various sizes</li>
<li>Oropharyngeal airways &ndash; various sizes</li>
<li>Nasopharyngeal airways &ndash; various sizes</li>
<li>LMA/Proseal LMA - #3, 4, 5</li>
</ul>
<p><strong>Drawer 4 &ndash; Plan D</strong></p>
<ul>
<li>Large bore cannula device e.g. Quicktrach I or II (VBM)</li>
<li>Scalpel (No. 20 blade)</li>
<li>Tracheal dilator or tracheal hook</li>
<li>Bougie</li>
<li>Cuffed tracheal tube #6 &amp; 7</li>
</ul>
<p><strong>Drawer 5 &ndash; Plan D</strong></p>
<ul>
<li>Kink-resistant jet ventilation cannula e.g. Ravussin (VBM)</li>
<li>High &amp;/or low pressure ventilation system e.g. Manujet III (VBM)</li>
<li>Ventrain (Ventinova)</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 56</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Clonidine is used to: </strong><strong>(Pharma)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Increase Low BP</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Decrease high BP</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Increase Pulse rate</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Decrease Pulse rate</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents.</li>
<li>Clonidine treats high blood pressure by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 57</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following vitamin deficiency leads to bleeding gums? </strong><strong>(FON)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Vitamin C</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Vitamin A</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Vitamin B</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Vitamin K</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Bleeding gums are the most common symptom of gum disease.</li>
<li>Deficiencies in Vitamin C and vitamin K can also cause gums to bleed easily.</li>
<li>Vitamin C helps with tissue growth and repair. It heals wounds as well as strengthens your bones and teeth. Vitamin C deficiency can result in swollen and bleeding with time.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 58</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>PDS suture is an example of: </strong><strong>(MSN)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Natural absorbable suture</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Synthetic absorbable suture</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Synthetic Non absorbable suture</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Natural Non absorbable suture</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>PDS (polydioxanone suture), a new synthetic absorbable suture. It is a slowly absorbable monofilament suture composed of the polyester, poly (p-dioxanone). This is a monofilament with greater strength than monofilament nylon and polypropylene and with less tissue drag than the multifilament materials.</li>
<li>Polydioxanone suture is available in violet color.</li>
<li>PDS sutures provide wound support for longer periods up to 50 days and offers far superior tensile strength and outstanding pliability. Its monofilament structure provides good handling properties and excellent knot security.</li>
<li>Absorption of suture is by simple hydrolysis within 180 days from implantation day</li>
<li>PDS sutures are ideal for use in general orthopedic surgery, sub cuticular, gastro intestinal tract, pediatric cardiovascular surgery, sheath closure and general surgery. PDS sutures also cause minimal tissue reaction.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 59</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>After death of a person, how long cornea can be preserved? </strong><strong>(MSN)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>2 Hours</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>6 Hours</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>8 Hours</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>12 Hours</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>The corneas should be removed preferably within an hour, but can be removed up to a maximum of 6 hours of death.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 60</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which snake venom causes rapid DIC? </strong><strong>(MSN)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Cobra</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Krait</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Viper</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Bandy-Bandy</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Viper bites produce hematotoxicity and coagulopathy which may be either true disseminated intravascular coagulation (DIC) or DIC-like syndrome.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 61</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The primary action of injection paracetamol is: </strong><strong>(Pharma)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Antiemetic</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Anti-motility</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Anti-Inflammatory</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Antipyretic</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Paracetamol is in a class of medications called analgesics (pain relievers) and antipyretics (fever reducers).</li>
<li>It works by changing the way the body senses pain and by cooling the body.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 62</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Identify the position shown in the image: </strong><strong>(FON)</strong></p>
<p><strong><img title="Picture001.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/5b698186-e1b9-441a-baf1-0e5d36543ff9.png" alt="" width="250" height="167" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Trendelenburg</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Reverse Trendelenburg</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Lithotomy</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Sims position</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Reverse Trendelenburg Position</strong></p>
<p><img title="Picture0001.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/e0c61809-4fb4-4e9d-a5de-65a9cadf35a4.png" alt="" width="280" height="129" /></p>
<p><strong>Figure 1: </strong>Reverse Trendelenburg Position</p>
<ul>
<li><strong>&nbsp;</strong>Reverse Trendelenburg position is typically used for laparoscopic, gallbladder, stomach, prostrate, gynecology, bariatric and head and neck surgeries.</li>
<li>Risks to a patient in this position include deep vein thrombosis, sliding and shearing, perineal nerve and tibial nerve.</li>
</ul>
<p><strong>Trendelenburg Position</strong></p>
<p><strong><img title="image104.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/c9fc4ed7-e072-443d-aacb-2be0abae4e4f.jpg" alt="" width="273" height="118" /></strong></p>
<p><strong>Figure 2: </strong>Trendelenburg Position</p>
<ul>
<li>In this position, the patient's arms should be tucked at their sides and the patient must be secured to avoid sliding on the surgical table.</li>
<li>Trendelenburg position is typically used for lower abdominal, colorectal, gynecology and genitourinary surgeries, cardioversion and central venous catheter placement.</li>
</ul>
<p><strong>Lithotomy Position</strong></p>
<p><strong><img title="image106.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/5bd7140b-766f-44fe-bf0b-86493003f342.jpg" alt="" width="265" height="124" /></strong></p>
<p><strong>Figure 3: </strong>Lithotomy Position</p>
<ul>
<li>In Lithotomy position, the patient can be placed in either a boot-style leg holder or stirrup-style position.</li>
<li>This position is typically used for gynecology, colorectal, urology, perineal or pelvis procedures.</li>
<li>Most commonly used during hemorrhoid and fissure surgeries.</li>
<li>The risks posed to a patient in a Lithotomy position for a procedure include fractures, nerve injuries, hip dislocation, muscle injuries, pressure injuries and diminished lung capacity.</li>
<li>Disadvantage: If lithotomy prolonged; leg not supported properly &rarr; improper paddling or over abduction &rarr; Injuries to common peroneal nerve.</li>
</ul>
<p><strong>Sim's Position</strong></p>
<p><strong><img title="image108.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/742d22df-d919-4fc4-9688-71ffbda30c63.jpg" alt="" width="289" height="111" /></strong></p>
<p><strong>Figure 4: </strong>Sim&rsquo;s Position</p>
<ul>
<li>The Sims' position is a variation of the left lateral position. The patient is usually awake and helps with the positioning. The patient will roll to his or her left side.</li>
<li>This position allows access to the anus, like Proctoscopy.</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 63</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Nicotine replacement therapy is used for: </strong><strong>(MSN)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Smoking cessation</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Alcohol withdrawal</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Opioid withdrawal</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Pontine hemorrhage</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Nicotine replacement products (NRPs) contain pure nicotine with an aim to reduce the patient's inclination towards tobacco consumption and the physiological and psychomotor withdrawal symptoms.</li>
<li>Nicotine replacement therapy (NRT) gives you nicotine &ndash; in the form of gum, patches, sprays, inhalers or lozenges &ndash; but not the other harmful chemicals in tobacco. NRT can help relieve some of the physical withdrawal symptoms so that you can focus on the psychological (emotional) aspects of quitting.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 64</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which electrolyte is closely monitored in digoxin administration? </strong><strong>(Pharma)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Sodium</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Calcium</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Potassium</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Phosphate</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Digoxin toxicity causes hyperkalemia or high potassium. The sodium/potassium ATPase pump normally causes sodium to leave cells and potassium to enter cells. Blocking this mechanism results in higher serum potassium levels.</li>
<li>Digoxin toxicity can be aggravated by potassium and magnesium levels, so a healthcare provider may monitor electrolytes and magnesium levels.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 65</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Identify the placental removal technique shown in the image: </strong><strong>(OBG)</strong></p>
<p><strong><img title="Picture005.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/873f743c-6bc4-4687-b4b0-bdf4d4620a6e.png" alt="" width="259" height="141" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Manual removal</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Cord traction by doctor</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Expulsion of placenta by fundal pressure</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Cesarean session</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Fundal pressure (Crede maneuver) involves placing one hand on the top of the uterus (uterine fundus) and squeezing it between the thumb and other fingers to help placental separation and delivery.</li>
<li>Controlled cord traction involves traction on the umbilical cord while maintaining counter-pressure upwards by placing a hand on the lower abdomen. Also, controlled cord traction should only follow signs of placental separation. Both these interventions, if not performed correctly, may have adverse outcomes including pain, hemorrhage and inversion of the uterus.</li>
</ul>
<p><strong>Indications for use of Manual Removal Procedures</strong></p>
<ul>
<li>The decision to attempt manual removal of the placenta and membranes in an otherwise normal labor and birth should be based on one of two indications:
<ul>
<li>The sudden occurrence of hemorrhage but the placenta gives no indication of delivering. This may mean that at least partial separation has occurred. A portion of the placenta may have remained adhered to the wall of the uterus.</li>
<li>Hemorrhage after the birth of the placenta and examination of the placenta also shows evidence of missing placental fragments, membranes or a cotyledon. This indicates the probability of retained tissue within the uterus.</li>
</ul>
</li>
</ul>
<p><img title="Picture006png.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/299ab259-6db0-40f4-8710-6c70c657226b.png" alt="" width="346" height="228" /></p>
<p><strong>Figure: </strong>Manual Removal Procedure</p>
<ul>
<li>Both of these events result in interference with the normal contraction of the uterus which usually enables the myofibrils of the uterine muscles to close off the small blood vessels and control bleeding. Removing the placenta and/or retained placental tissue and membranes is the critical first step to enable the uterus to contract effectively and stop the hemorrhage.</li>
<li><strong>Preparation: </strong>
<ul>
<li>Quickly draw a sterile glove over your existing glove on your dominant hand. One size larger than the gloves you are wearing may be put on more rapidly.</li>
<li>Fold a sterile towel on the mother's abdomen with the opening facing you. Place your non-dominant hand between the folds of the towel and grasp the uterus through the abdominal wall. The side of your hand should be around the fundus and your thumb just above the symphysis pubis.</li>
<li>Draw the uterus downward and continue to hold it stable with your hand.</li>
</ul>
</li>
<li><strong>Extraction of the placental tissue and membranes within the uterus:</strong>&nbsp;Make a cone with your dominant hand by holding the tips of your fingers and thumb together. Enter the vagina and gently push against the cervix to open it further, as you go into the lower portion of the uterus.</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 66</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following is not used before ECT Procedure? </strong><strong>(FON)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Have light meal before the procedure</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Premedication with anticholinergics</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>NPO</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Wash the oils from Hair</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Because electroconvulsive therapy is performed under general anesthesia, you should not eat, drink or smoke after midnight on the days of your treatments.</li>
<li>Do not drink alcohol or use any illegal drugs over the course of the treatment.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 67</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Identify the investigation image shown below: </strong><strong>(MSN)</strong></p>
<p><strong><img title="Picture007.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/48e7584d-1179-49e7-8684-aff4bb6d215f.png" alt="" width="250" height="192" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>CT brain</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>MRI Brain</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>CT KUB</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>MRI KUB</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Computed tomography of kidneys, ureters and bladder (CT KUB) is a quick non-invasive technique for diagnosis of urolithiasis. It is usually considered the initial imaging modality for suspected urolithiasis in an emergency setting.</li>
<li>A CT brain is ordered to look at the structures of the brain and evaluate for the presence of pathology, such as mass/tumor, fluid collection (such as an abscess), ischemic processes (such as a stroke). It is particularly good for hemorrhage, trauma or fracture to the skull and for hydrocephalus.</li>
</ul>
<p><img title="Picture008.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/1c8180d8-44bf-40ee-b5d8-e04781fc3470.png" alt="" width="169" height="169" /></p>
<p><strong>Figure 1:</strong> CT Brain</p>
<ul>
<li>Magnetic resonance imaging (MRI) of the brain is a safe and painless test that uses a magnetic field and radio waves to produce detailed images of the brain and the brain stem. An MRI differs from a CAT scan (also called a CT scan or a computed axial tomography scan) because it does not use radiation.</li>
</ul>
<p><img title="Picture009.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/ccae90c3-16c4-41e5-8ab8-d4d2a7593e33.png" alt="" width="180" height="180" /></p>
<p><strong>Figure 2: </strong>MRI Brain</p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 68</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Use of vaporizers in OT is to: </strong><strong>(MSN)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Maintain required humidity in OT</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Makes sure required number of air exchange occurred in OT</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Deliver given concentration of volatile anesthetic agent.</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>disinfect environmental air in OT</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Vaporizers works by controlling the vaporization of anesthetic agents from liquid and then accurately controlling the concentration in which these are added to the fresh gas flow.</li>
<li>The design of these devices takes account of varying: ambient temperature, fresh gas flow and agent vapor pressure.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 69</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following antipsychotic drug causes hyperprolactinemia? </strong><strong>(Pharma)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Clozapine</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Risperidone</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Quetiapine</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Olanzapine</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Risperidone is an atypical antipsychotic that can cause hyperprolactinemia</li>
<li>Treatment of schizophrenia with risperidone may cause a substantial plasma prolactin increase and an unacceptably high incidence of prolactin related symptoms (PRS), such as amenorrhea, galactorrhea, gynecomastia and sexual dysfunction.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 70</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Clinically used form of lithium is: </strong><strong>(Pharma)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Lithium Oxalate</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Lithium Disodium</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Lithium Carbonate</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Lithium Permanganate</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Lithium is one of the most widely used medications for treating bipolar disorder.</li>
<li>Lithium helps reduce the severity and frequency of mania. It may also help relieve or prevent bipolar depression.</li>
<li>There are 2 different types of lithium &ndash; lithium carbonate and lithium citrate.
<ul style="list-style-type: circle;">
<li>Lithium carbonate is used to treat manic-depressive disorder (bipolar disorder). It works to stabilize the mood and reduce extremes in behavior by restoring the balance of certain natural substances (neurotransmitters) in the brain.</li>
</ul>
</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 71</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which blood group is known as universal recipients? </strong><strong>(FON)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Negative</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Positive</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>AB Positive</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>AB Negative</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Type AB-positive blood is called the "universal recipient" type because a person who has it can receive blood of any type.</li>
<li>Type O-negative blood does not have any antigens. It is called the "universal donor" type because it is compatible with any blood type.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 72</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Identify the image shown below: </strong><strong>(FON)</strong></p>
<p><strong><img title="da.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/768bef4d-9156-4bfa-9612-6839f41ccde2.png" alt="" width="152" height="187" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Boiler</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Autoclave</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Fumigator</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Vaccine container</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>An autoclave is a machine that uses steam under pressure to kill harmful bacteria, viruses, fungi and spores on items that are placed inside a pressure vessel.</li>
<li>The moisture in the steam efficiently transfers heat to the items to destroy the protein structure of the bacteria and spores.</li>
<li>Autoclave: Autoclaves operate at high temperature and pressure in order to kill microorganisms and spores. They are used to&nbsp;<strong>decontaminate certain biological waste and sterilize media, instruments and lab ware</strong>.</li>
<li>Boiler: Boiler is defined as a closed vessel in which steam is produced from water by the combustion of fuel. They are also called Steam Generators. Generally, steam is produced in boilers by the interaction of hot flue gases coming out from the fuel mainly coal or coke and water flowing through pipes. In boilers chemical energy of stored fuel is converted into heat energy and this heat energy is absorbed by water and converts to steam.</li>
</ul>
<p><img title="121.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/bb8df053-8617-4a71-bae4-a67be7562e42.png" alt="" width="305" height="209" />&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<strong> </strong></p>
<ul>
<li>Vaccine container: Vaccine carriers are insulated containers that, when lined with coolant packs, keep vaccines and diluents cold during transportation. They are smaller than cold boxes and are easier to carry when walking. They are used for transporting vaccines from health facilities with refrigeration to outreach sessions where refrigeration and ice are not available.</li>
</ul>
<p><img title="123.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/2fac9b35-60c9-4c24-b7b5-36e3e3035dce.png" alt="" width="300" height="158" /></p>
<ul>
<li>Fumigator: <strong>Fumigation</strong>is a method of&nbsp;pest control/ removal of harmful micro-organisms that completely fills an area with gaseous&nbsp;pesticides&mdash;or&nbsp;<strong>fumigants</strong>&mdash;to suffocate or poison the pests within. It is used to control pests in buildings (structural fumigation), soil, grain and produce and is also used during processing of goods to be imported or exported to prevent transfer of&nbsp;exotic organisms. This method also affects the structure itself, affecting pests that inhabit the physical structure, such as&nbsp;woodborers&nbsp;and dry wood&nbsp;termites.</li>
</ul>
<p><img title="dasda.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/97e9195b-d7f9-45dd-be7f-724152a6a3d7.jpg" alt="" width="200" height="207" /></p>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 73</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Heimlich maneuver is used to treat: </strong><strong>(FON)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Lower airway obstruction</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Nasal Obstruction</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Tracheal Obstruction</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Upper airway obstruction</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>The Heimlich maneuver (abdominal thrusts) is a rapid first-aid procedure to treat choking due to upper airway obstruction by a foreign object, typically food or a toy.</li>
<li>If a victim was choking before falling unconscious, the Heimlich maneuver may be used to clear the airway before beginning mouth-to-mouth respiration.</li>
</ul>
<p><img title="17.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/0886ab28-1c52-4b32-a651-72362e2960d2.jpg" alt="" width="502" height="217" /></p>
<p><strong>Figure: </strong>Heimlich Maneuver</p>
<ul>
<li>To perform abdominal thrusts (Heimlich maneuver) on someone else:</li>
<li><strong>Stand behind the person:</strong> Place one foot slightly in front of the other for balance. Wrap your arms around the waist. Tip the person forward slightly. If a child is choking, kneel down behind the child.</li>
<li><strong>Make a fist with one hand:</strong> Position it slightly above the person's navel.</li>
<li><strong>Grasp the fist with the other hand:</strong> Press hard into the abdomen with a quick, upward thrust &mdash; as if trying to lift the person up.</li>
<li><strong>Perform between six and 10 abdominal thrusts</strong> until the blockage is dislodged.</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 74</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Extra calories needed during second trimester of pregnancy is: </strong><strong>(OBG)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>200 Kcal/day</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>500 Kcal/day</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>600 Kcal/day</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>700 Kcal/day</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Table:</strong> Sample Snacks in Pregnancy</p>
<p><img title="16.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/1c55afc6-fbc7-410b-a860-bd904ef09b97.jpg" alt="" width="500" height="280" /></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 75</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which is not an adverse effect of clozapine? </strong><strong>(Pharma)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Weight Gain</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Hypersalivation</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Hepatotoxicity</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Tachycardia</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Clozapine is a psychiatric medication (anti-psychotic type) that works by helping to restore the balance of certain natural substances (neurotransmitters) in the brain.</li>
<li>This medication is used to treat certain mental/mood disorders (schizophrenia, schizoaffective disorders).</li>
<li>Commonly reported side effects of clozapine include: Drooling, drowsiness, dizziness, lightheadedness, headache, shaking (tremor), vision problems (e.g. blurred vision), constipation and weight gain.</li>
<li>Other side effects include: syncope and diaphoresis.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 76</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Use of epinephrine will cause which of the following symptoms? </strong><strong>(Pharma)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Bradycardia</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Tachycardia</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Decreased BP</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Tachypnea</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Epinephrine, more commonly known as adrenaline, is a hormone secreted by the medulla of the adrenal glands. Strong emotions such as fear or anger cause epinephrine to be released into the bloodstream, which causes an increase in heart rate, muscle strength, blood pressure and sugar metabolism.</li>
<li>Epinephrine over dosage can also cause <strong>transient bradycardia</strong> followed by<strong> tachycardia</strong> and these may be accompanied by potentially fatal cardiac arrhythmias.</li>
<li>Premature ventricular contractions may appear within one minute after injection and may be followed by multifocal ventricular tachycardia (prefibrillation rhythm).</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 77</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>In which of the following vaccine, cold chain has to be maintained? </strong><strong>(FON)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Killed Vaccine</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Live vaccine</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Toxoids</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Serums</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Delivering vaccines to all corners of the world is a complex undertaking. It takes a chain of precisely coordinated events in temperature-controlled environments to store, manage and transport these life-saving products. This is called a cold chain.</li>
<li>Live vaccines use a weakened (or attenuated) form of the germ that causes a disease. Because these vaccines are so similar to the natural infection that they help prevent, they create a strong and long-lasting immune response.</li>
<li>Vaccines should be stored in the refrigerator in their original packaging. Vaccines must never be stored in the door of the refrigerator.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 78</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following is not transmitted by needle stick injury?</strong><strong> (FON)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>HIV</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Hepatitis B</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Scrub Typhus</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Hepatitis C</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Scrub typhus, also known as bush typhus, is a disease caused by a bacteria called <em>Orientia tsutsugamushi</em>. Scrub typhus is spread to people through bites of infected chiggers (larval mites).</li>
<li>Needle stick injuries are wounds caused by needles that accidentally puncture the skin. Needle stick injuries are a hazard for people who work with hypodermic syringes and other needle equipment. These injuries can occur at any time when people use, disassemble or dispose of needles.</li>
<li>Hepatitis B and HIV are transmitted by needle stick injury.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 79</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Cyanotic spell is seen in: </strong><strong>(MSN)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Atrial septal defect</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Ventricular septal defect</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Tetralogy of Fallot</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Trans position of arteries</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Patients of complete TGA with intact ventricular septum are cyanotic at birth since they have two parallel circulations. The ductus is the only link between the pulmonary and systemic circulation.</li>
<li>In Tetralogy of Fallot, Cyanosis presents after 7 days.</li>
<li>VSD and PDA are Acyanotic heart diseases.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 80</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Side effect of clozapine includes: </strong><strong>(Pharma)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Agranulocytosis</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Nausea</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Vomiting</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Diarrhea</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Agranulocytosis is a serious side effect associated with clozapine use, which involves a dangerously low level of neutrophils in the blood, increasing the risk of infections. While nausea, vomiting, and diarrhea can also occur, agranulocytosis is the most significant and potentially life-threatening side effect.</li>
<li>Clozapine is an antipsychotic medicine, used to reduce the risk of suicidal behavior in people with schizophrenia or similar disorders.</li>
<li>Clozapine can cause a decrease in white blood cells; you will need to get blood tests done regularly as directed.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 81</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following is primary prevention in skin cancer? </strong><strong>(MSN)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Applying sunscreen creams and lotions while going out</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Professional skin examination and self-skin examination</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Early diagnosis and initiation of treatment for skin cancer</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Health education regarding treatment compliance of chemotherapy</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>The incidence of skin cancer is increasing worldwide.</li>
<li>Protecting the skin from the sun by wearing protective clothing, using a sunscreen with appropriate sun protection factor, wearing a hat and avoiding the sun are recommended as primary preventive activities by cancer agencies.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 82</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Most painful type of burns is: </strong><strong>(MSN)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>First degree burns</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Second degree burns</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Third degree burns</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Fourth degree burns</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li><strong>First degree:</strong> Here the epidermis looks red and painful, no blisters, heals rapidly in 5 - 7 days by Epithelialization without scarring. It shows capillary filling.</li>
<li><strong>Second degree:</strong> The affected area is mottled, red, painful with blisters, heals by epithelialization in 14 - 21 days.
<ul style="list-style-type: circle;">
<li>Superficial second degree burn heals, causing pigmentation.</li>
<li>Deep second degree burn heals by causing scarring and pigmentation. Sensation is present but no blanching.</li>
</ul>
</li>
<li><strong>Third degree:</strong> The affected area is charred, parchment like, painless and insensitive, with thrombosis of superficial vessels. It requires grafting. Charred, denatured, insensitive, contracted full thickness burn is called as <strong>eschar</strong>. These wound must heal by re-epithelialization from wound edge.</li>
<li><strong>Fourth degree:</strong> Involves the underlying tissues-muscles, bones.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 83</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Scrubbing will be considered as: </strong><strong>(FON)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Chemical disinfection</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Physical disinfection</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Physical sterilization</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Chemical sterilization</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Physical means of disinfection do not involve the addition of chemicals, but disrupt normal microbial function or cause structural damage to pathogens through physical means. An effective physical disinfection process is safe, energy efficient, consistently effective and cost-effective at a larger scale.</li>
<li>Physical methods to disinfect water include <strong>UV irradiation, heat, sunlight exposure, sonic or hydrodynamic pressure and radiation</strong>.</li>
<li>These processes inactivate pathogens by denaturing proteins (heat, sunlight), causing mechanical stress to the pathogen that leads structural damage (sonication, hydrodynamic, cavitation) or through nucleic acid (DNA/RNA) and protein damage (UV, sunlight, radiation) to the pathogen.</li>
<li>Some of these processes can also create reactive oxygen species within the water matrix that cause oxidative damage to pathogenic microorganism.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 84</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Atrio-Venous fistula is assessed for: (MSN)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Giving IV medication</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Blood sampling</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Arterial BP</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Patency</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>An arteriovenous (AV) fistula is an abnormal connection between an artery and a vein. Normally, blood flows from your arteries to your capillaries and then on to0 your veins. Nutrients and oxygen in your blood travel from your capillaries to tissues in your body.</li>
<li>Assisted primary patency is the thrombosis-free access survival. Secondary patency ends when the access is abandoned (14). A functional AVF is an access that is able to deliver a flow rate of 350 to 400 mL/min without recirculation for the total duration of dialysis.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 85</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>PAP Smear test is used in the diagnosis of: </strong><strong>(MSN)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Uterine Cancer</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Cervical Cancer</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Vulval Cancer</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Ovarian Cancer</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>A Pap smear, also called a Pap test, is a procedure to test for cervical cancer in women.</li>
<li>A Pap smear involves collecting cells from your cervix &mdash; the lower, narrow end of your uterus that's at the top of your vagina. Detecting cervical cancer early with a Pap smear gives you a greater chance at a cure.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 86</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The relationship between fetal presenting part and maternal pelvis is known as_______________. </strong><strong>(OBG)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Attitude</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Lie</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Position</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Presentation</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li><strong>Fetal Lie:</strong> Using the techniques described above, the clinician should be able to develop an assessment of the relationship between the <strong>fetal and maternal dorsal columns (the longitudinal axis of the human body).</strong> If the fetus and maternal column are parallel (on the same long axis), the lie is termed vertical or longitudinal lie. This is the most common lie of fetuses in labor.</li>
<li><strong>Attitude:</strong> In addition to having a lie, the fetus has an attitude. This is defined as the relation of the <strong>various parts of the fetus to each other</strong>. In the normal attitude, the fetus is in universal flexion. The anatomic explanation for this posture is that it enables the fetus to occupy the least amount of space in the intrauterine cavity. The fetal attitude is extremely difficult, if not impossible, to assess without the help of an ultrasound examination.</li>
<li><strong>Presentation:</strong> After the lie of the fetus is assessed, the clinician has to detail the fetus further by describing the <strong>lowermost structure of the fetus in the maternal pelvis. </strong>This is referred to as the <strong>fetal presentation</strong>. In a vertical (or longitudinal) lie, the fetal presentation can be either cephalic or breech. In the transverse lie, the presentation is usually the back or shoulder; in the oblique lie, it is usually the shoulder or the arm.</li>
<li><strong>Position:</strong> The next step in the assessment of the fetus consists of determining the position of the presenting part. This is a description of the <strong>relation of the presenting part of the fetus to the maternal pelvis</strong>. In the case of a longitudinal lie with a vertex presentation, the occiput of the fetal calvarium is the landmark used to describe the position. When the occiput is facing the maternal pubic symphysis, the position is termed <strong>direct occiput anterior</strong>. If the occiput is between the ischial spines and the symphysis, it is called either <strong>a right or left occiput anterior</strong>. If the occiput is located halfway between the promontorium of the sacrum and the symphysis, the position is termed either a <strong>left or right occiput transverse</strong>. As the occiput approaches the sacrum, it becomes either <strong>a right or left occiput posterior</strong>. When the occiput is straight down (i.e. facing the sacrum or coccyx), the position is called <strong>direct occiput posterior</strong>.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 87</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The nurse is providing indwelling catheter care to her assigned male patient. After cleaning the glans penis, the nurse noticed that the foreskin is not retracted back to its original position. On documentation the nurse will use which terminology to express this condition? </strong><strong>(MSN)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Phimosis</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Paraphimosis</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Hypospadias</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Circumcision</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li><strong>Paraphimosis</strong>: This occurs when the foreskin has been retracted behind the glans penis and cannot be returned to its original position. This condition can cause swelling and pain and may require urgent medical intervention to avoid complications like impaired blood flow to the glans.</li>
<li><strong>Phimosis</strong>: This condition refers to a situation where the foreskin cannot be retracted over the glans penis due to a tight opening. It is common in newborns and usually resolves on its own as the child grows. In some cases, it may require treatment if it causes issues like infections or difficulty with urination.</li>
<li><strong>Hypospadias</strong>: This is a congenital condition where the urethral opening is not located at the tip of the penis but rather on the underside. It is not directly related to the foreskin but involves the anatomy of the penis and may require surgical correction.</li>
<li><strong>Circumcision</strong>: This is a surgical procedure that involves the removal of the foreskin from the penis. It is often performed for cultural, religious, or medical reasons and eliminates the issues associated with phimosis and paraphimosis.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 88</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following contraceptive method is contraindicated in a woman who smokes one pack of cigarette daily? </strong><strong>(OBG)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Oral contraceptive pills</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>IUD</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Diaphragm</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Cervical Cap</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use.</li>
<li>Oral contraceptive pills are contraindicated in women who smoke one pack of cigarettes daily, particularly if they are over the age of 35. This is due to an increased risk of thromboembolism (blood clots) associated with both smoking and the use of estrogen-containing contraceptives. The other methods listed (IUD, diaphragm, cervical cap) do not carry the same level of risk related to smoking. &nbsp;</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 89</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>All of the following are the component of &ldquo;Sign in&rdquo; surgical safety checklist, except: </strong><strong>(MSN) &nbsp;&nbsp;</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Patient identification</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Administration of antibiotic prophylaxis</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Completing anesthesia safety checklist</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Site marking</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>The checklist divides the operation into three phases, each corresponding to a specific time period in the normal flow of a procedure &mdash; the period before induction of anesthesia <strong>(Sign In),</strong> the period after induction and before surgical <strong>incision (Time Out) and</strong> the period during or immediately after wound closure but before removing the patient from the operating room <strong>(Sign Out). &nbsp;&nbsp;&nbsp;&nbsp;</strong></li>
<li>In each phase, the checklist coordinator must be permitted to confirm that the team has completed its tasks before it proceeds further. As operating teams become familiar with the steps of the checklist, they can integrate the checks into their familiar work patterns and verbalize their completion of each step without the explicit intervention of the checklist coordinator. &nbsp;</li>
<li>Each team should seek to incorporate use of the checklist into its work with maximum efficiency and minimum disruption, while aiming to accomplish the steps effectively.</li>
</ul>
<p><strong>Table: </strong>Pre-anesthetic checklist</p>
<p><img title="14.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/6734cd76-95a6-4f7c-b126-04ef59ae8d91.jpg" alt="" width="251" height="400" /></p>
<p><img title="15.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/b7e82fe7-e19f-4c6b-b178-d5fbcb8534ff.jpg" alt="" width="538" height="461" /></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 90</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>You are providing care to the patient following LSCS in post-operative unit. On assessment you observe the total output in 400 mL in last 24 hours. The correct terminology to express this condition will be:</strong><strong> (OBG)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Oliguria</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Polyuria</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Anuria</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Hematuria</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Oliguria is defined as urine output of less than 400 mL/24 hours.</li>
<li>Anuria describes the failure to produce or release urine. It may be due to kidney failure or an obstruction in the urinary pathway. Anuria is defined as a urine output of less than 100 mL/day.</li>
<li>Blood in the urine is hematuria.</li>
<li>Excessive urine production is called polyuria. Polyuria is defined as the frequent passage of large volumes of urine &ndash; more than 3 liters a day compared to the normal daily urine output in adults of about 1 to 2 liters.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 91</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Select the order in which the nurse will perform the abdominal assessment of a patient admitted in the surgery ward with the chief complaint of abdominal pain? </strong><strong>(MSN) </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Inspection, Palpate, Percussion, Auscultate</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Inspection, Auscultation, Palpation, Percussion</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Inspection Auscultation, Percussion, Palpation</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Inspection, Percussion, Palpation, Auscultation</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>SEQUENCE OF PHYSICAL EXAMINATION </strong></p>
<p>Physical examination follows a sequence to rule out any illness effectively and also for the convenience of the examiner and patient.</p>
<ul>
<li>Steps of Physical examination in case of all systems <strong>except abdomen</strong> are:</li>
</ul>
<ol>
<li><strong>Inspection </strong>This is the first step of the physical examination in which we just do careful inspection to distinguish between normal and abnormal by observing the patient superficially for any visible deformity, any scar, rash, wound, change in color of skin, hearing and smelling. For the inspection we need to be expert to practice these skills. Inspect each area for size, shape, symmetry, color and check for side-to-side symmetry by comparing both sides of body simultaneously.</li>
<li><strong>Palpation</strong> It involves touching the patient by using the finger pads to make judgements about underlying tissue, muscles and organs. This technique could be used for palpating the skin for texture, tenderness and any mass in the body, such as skin, liver intestine, glands like thyroid, blood vessels such as carotid and femoral artery.</li>
<li><strong>Percussion </strong>This technique involves the tapping on the finger placed on the body surface with other finger to vibrate the underlying tissue and organs. That sound will reach up-to underlying tissues and reflects back the density of those tissues. It can rule out fluid filled space, any lesion, mass or air-filled cavity.</li>
<li><strong>Auscultation </strong>It involves the listening of the sounds of the body at different areas by using the stethoscope. This can be done for auscultating the heart sounds, breathing sounds, abdominal sounds.</li>
</ol>
<ul>
<li>Sequence in case of <strong>Abdomen </strong>will be:
<ol>
<li>Inspection</li>
<li>Auscultation</li>
<li>Percussion</li>
<li>Palpation</li>
</ol>
</li>
<li>In case of abdomen we perform auscultation before palpation because palpation can alter the frequency and intensity of the bowel sounds.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 92</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The most preferred site for ABG sampling is: </strong><strong>(MSN)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Radial artery</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Femoral artery</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Brachial artery</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Ulnar artery</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Radial artery is the preferred site for ABG sampling.</li>
<li>Before drawing an ABG, the nurse assesses the collateral circulation to the hand with Allen&rsquo;s test. This involves compressing the radial and ulnar arteries and asking the patient to close and open the fist. This should cause the hand to become pale.</li>
<li>The nurse then releases pressure on one artery and observes whether circulation is restored quickly. The nurse repeats the process, releasing the other artery. The blood sample may be taken safely if collateral circulation is adequate.</li>
<li>Puncture of the radial artery is usually preferred because of the accessibility of the vessel, the presence of collateral circulation and the artery&rsquo;s superficial course proximal to the wrist, which makes it easier for the clinician to identify the vascular structure and hold local pressure after the procedure is finished.</li>
<li>If radial artery sampling is not feasible, femoral artery puncture is a possible alternative. When femoral artery puncture is being considered, the potential risk of infection at the entry site and the artery&rsquo;s proximity to the femoral vein and nerve must be taken into consideration.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 93</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A pregnant patient (18 weeks of gestation) admitted in emergency with chief complaint of abdominal cramping and vaginal bleeding. On examination the cervix is not dilated. Most likely type of abortion will be: </strong><strong>(OBG)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Threatened</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Complete</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Incomplete</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Missed abortion</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Spontaneous Abortion</strong></p>
<ul>
<li>Loss of a clinically recognized pregnancy before 20 weeks&rsquo; gestation or &lt;500 g.</li>
<li>Make up 15 &ndash; 20% of clinically diagnosed pregnancies.</li>
<li>Risk factors include advanced maternal age, increasing gravidity, prior miscarriage and smoking.</li>
<li><strong>History:</strong> Vaginal bleeding is the most common presenting complaint, followed by crampy abdominal pain.</li>
<li><strong>Examination:</strong> Initially, vital signs should be taken to rule out hemodynamic instability. Speculum examination allows visualization of the cervix and potentially the location of products of conception. Bimanual examination may help estimate gestational age.</li>
<li><strong>Laboratory tests:</strong> Serum human choronic gonadotropin (hCG), blood count and rhesus (Rh) typing should be sent (virtually all Rh-negative patients should receive anti-D immunoglobulin prophylaxis.</li>
</ul>
<p><strong>Causes: </strong></p>
<ul>
<li>More than 80% of all miscarriages occur in the first trimester (&lt;12 weeks&rsquo; gestation). The exact mechanisms are not always apparent, but death of the embryo or fetus nearly always precedes spontaneous expulsion. As a result, finding the cause of early miscarriage involves ascertaining the cause of fetal death. At least half result from chromosomal abnormalities.</li>
<li>Less than 20% of all miscarriages occur in the second trimester (12 &ndash; 20 weeks&rsquo; gestation). The fetus frequently does not die before expulsion and anatomic factors are more likely to be causative.</li>
</ul>
<p><strong>Incomplete miscarriage</strong></p>
<ul>
<li>Incomplete miscarriages usually occur between 6 and 14 weeks gestation.</li>
<li>Here the entire products of conception are not expelled but a part is left inside the uterine cavity.</li>
<li><strong>Sign and Symptoms:</strong></li>
<li>Uterine bleeding with cervical dilation but with incomplete expulsion of the product of conception (POC).</li>
<li>Continuous, colicky lower abdominal pain</li>
<li><strong>Size of uterus:</strong> Smaller</li>
<li><strong>Internal Os:</strong> Open</li>
<li><strong>Investigation:</strong> Retained products in USG</li>
<li><strong>Management:</strong></li>
<li>If the patient is in shock due to blood loss, she should be resuscitated before any active treatment is undertaken.</li>
<li>In case of early abortion (before 12 weeks&rsquo;), dilation and evacuation under general anesthesia is to be done.</li>
<li>In late abortion, uterus is evacuated under general anesthesia and the products are removed by ovum forceps or by blunt curette. The remove products are subjected to a histological examination.</li>
</ul>
<p><strong>Complete miscarriage</strong></p>
<ul>
<li>Complete miscarriages are most common &lt;6 or &gt;14 weeks&rsquo;.</li>
<li>Here the products of conception are expelled in masse.</li>
<li><strong>Sign and Symptoms:</strong> Uterine bleeding with complete expulsion of the product of conception (POC) and closed cervical os.</li>
<li><strong>Size of uterus:</strong> Smaller</li>
<li><strong>Internal Os:</strong> Closed</li>
<li><strong>Investigation: </strong></li>
<li>On examination, the expelled flashy mass is found.</li>
<li>USG: Cavity empty</li>
<li><strong>Management: </strong></li>
<li>Complete miscarriages may be managed expectantly without evacuation.</li>
</ul>
<p><strong>Missed abortion</strong></p>
<ul>
<li>Fetal demise before 20 weeks&rsquo; gestation without detachment of the placenta &ndash; resulting in retention of products of conception for days or weeks behind a closed cervical os.</li>
<li>When the fetus is dead and retained inside the uterus for a variable period, it is known as missed abortion</li>
<li>Continuous brown vaginal discharge occurs after the demise.</li>
<li>Many women have no other symptoms.</li>
<li><strong>Size of uterus:</strong> Smaller</li>
<li><strong>Internal Os:</strong> Closed</li>
</ul>
<p><strong>Investigation: </strong></p>
<ul>
<li><strong>Sonogram findings</strong>:
<ul style="list-style-type: circle;">
<li>Dead fetus</li>
<li>A nonviable pregnancy without vaginal bleeding, uterine cramping or cervical dilation.</li>
<li>Mean sac diameter &ge;25 mm or crown rump length &ge; 7 mm with no fetal heart beat.</li>
<li>Coagulopathy also very rarely seen due to prolonged retention of a dead fetus after mid pregnancy.</li>
</ul>
</li>
<li><strong>Management:</strong>
<ul style="list-style-type: circle;">
<li>It is individualized, depending on the circumstances.</li>
<li>Medical management is often the safest option. Conservative management awaiting a spontaneous completed abortion or induce contractions with misoprostol (Cytotec&reg;) (PGE<sub>1</sub>).</li>
<li>Scheduled suction D&amp;C, conservative management awaiting a spontaneous completed abortion or induce contractions with misoprostol (Cytotec) (PGE<sub>1</sub>).</li>
<li>Expectant management is often difficult for the patient to endure after being informed of the demise.</li>
</ul>
</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 94</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Identify the pulse being palpated in the given image:</strong><strong> (FON)</strong></p>
<p><strong><img title="13.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/10987e3b-598f-496f-9f9c-3273580820b5.png" alt="" width="200" height="134" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Popliteal</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Posterior Tibial</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Dorsalis pedis</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Femoral</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Temporal pulse - The temporal pulse (i.e. superficial temporal artery) is palpated on the temple directly in front of the ear with the index finger.</li>
<li>Carotid artery pulse - The common carotid artery is palpated on the neck below the jaw and lateral to the larynx/trachea (i.e. mid-point between your earlobe and chin) using the middle and index fingers.</li>
<li>Brachial artery pulse - The brachial artery is palpated on the anterior aspect of the elbow by gently pressing the artery against the underlying bone with the middle and index fingers. The brachial artery pulse is commonly used to measure blood pressure with a stethoscope and sphygmomanometer.</li>
<li>Radial artery pulse - The radial pulse is palpated immediately above the wrist joint near the base of the thumb (i.e. common site) or in the anatomical snuff box (i.e. alternative site), by gently pressing the radial artery against the underlying bone with the middle and index fingers.</li>
<li>Femoral pulse - The femoral pulse is palpated over the ventral thigh between the pubic symphysis and anterior superior iliac spine with the middle and index fingers.</li>
<li>Popliteal pulse - The popliteal pulse is palpated on the posterior knee with the middle and index fingers; this pulse is more difficult to palpate as compared to other pulse sites.</li>
<li>Posterior tibial pulse - The posterior tibial pulse is palpated posterior and inferior to the medial malleolus by gently pressing the tibial artery against the underlying bone with the middle and index fingers.</li>
<li>Dorsalis pedis pulse - The dorsalis pedis pulse is palpated in the groove between the first and second toes slightly medial on the dorsum of the foot (i.e. dorsal-lateral to the extensor hallucis longus tendon and distal to the dorsal prominence of the navicular bone) with the middle and/or index fingers.</li>
<li>Apical pulse - The unilateral apical pulse (i.e. apex of the heart) can be located in the fifth intercostal space immediately to the left of the sternum using a stethoscope. In contrast to other pulses, the apical pulse is measured over the heart and not an artery and is commonly heard with a stethoscope as opposed to palpated.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 95</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>You are assigned to provide care to a patient with humerus fracture. After the application of plaster cast, which clinical findings indicate that the patient is experiencing compartment syndrome? </strong><strong>(MSN)&nbsp; &nbsp;</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Tingling and numbness</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Pain at fracture site</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Spasm in finger</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Both a &amp; c</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Compartment syndrome is a serious complication of casting and splinting. Ischemia and irreversible neuromuscular damage can occur.</li>
<li>The first action should be to notify the physician.</li>
<li>Applying ice and elevating the arm will worsen the condition further</li>
</ul>
<p><strong>Compartment syndrome </strong></p>
<ul>
<li>This is most frequent in the lower leg.</li>
<li>Pain out of proportion to clinical situation is usually first symptom in Compartment Syndrome of leg while Pain on passive stretching is most sensitive sign prior to onset of ischemia.</li>
</ul>
<p><strong>History</strong></p>
<ul>
<li>Prolonged ischemia followed by reperfusion, crushing injuries or other types of trauma.</li>
</ul>
<p><strong>Mnemonics: </strong></p>
<ul>
<li><strong>P</strong>ain with passive motion of the fingers and toes</li>
<li><strong>P</strong>ulselessness</li>
<li><strong>P</strong>allor</li>
<li><strong>P</strong>aresthesia</li>
<li><strong>P</strong>oikilothermia</li>
<li><strong>P</strong>aralysis</li>
</ul>
<p><strong>Mnemonics- 6P</strong></p>
<ul>
<li>Late signs of compartment syndrome: <strong>Paralysis and pulselessness</strong>.</li>
</ul>
<p><strong>Diagnosis</strong></p>
<ul>
<li><strong>Stretch test:</strong> This is the earliest sign of impending compartment syndrome.</li>
<li>Elevated compartment pressures (although not necessary).</li>
<li>If delta pressure &le; 30 mmHg is indicative of compartment syndrome.</li>
<li><strong>Delta pressures = Diastolic pressure &ndash; Compartment pressure</strong></li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 96</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The nurse is caring for a patient with a nasogastric tube that is attached to low suction. The nurse monitors the patient, for which acid-base disorder? </strong><strong>(FON)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Metabolic acidosis</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Metabolic alkalosis</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Respiratory acidosis</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Respiratory alkalosis</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>The main complications of NG tube insertion include a<strong>spiration and tissue trauma</strong>.</li>
<li>Placement of the catheter can induce gagging or vomiting, therefore suction should always be ready to use in the case of this happening.</li>
<li>Loss of acid as occurs with vomiting or nasogastric suction is a common cause of <strong>metabolic alkalosis</strong> maintained by volume contraction.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 97</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>You are a scrub nurse posted in an OT, you are asked to identify the marked arrow</strong><strong>, what will be your answer?</strong></p>
<p><strong><img title="6.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/428c9cad-d198-49df-b73e-982d4944bc96.png" alt="" width="201" height="159" /></strong></p>
<p>&nbsp;</p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Flow of CO<sub>2</sub> during exhalation which is low</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Flow of CO<sub>2</sub> during exhalation which is normal</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Flow of CO<sub>2</sub> during exhalation which is high</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Flow of CO<sub>2</sub> during inhalation which normal</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>End-tidal CO<sub>2</sub> - EtCO<sub>2</sub> is a noninvasive technique which represents the partial pressure or maximal concentration of CO<sub>2</sub> at the end of exhalation.</li>
<li>Normal value is 35 - 45 mmHg.</li>
</ul>
<p><strong>Capnogram: </strong></p>
<ul>
<li>It is a continuous concentration time display of the CO<sub>2</sub> sampled at a patient&rsquo;s air during ventilation.</li>
<li>The Capnograph during ventilation.</li>
</ul>
<p><img title="11.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/54ec0d4e-fc30-4737-8683-effa3e9a67f3.jpg" alt="" width="350" height="197" /></p>
<p><img title="12.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/648e7717-2390-40d7-a509-1d3c957c5ab2.jpg" alt="" width="352" height="275" /></p>
<ul>
<li><strong>First Phase (A-B):</strong> Represents the initial stage of expiration. Gas occupying anatomic dead space, devoid of CO<sub>2</sub> represents this phase.</li>
<li><strong>Second Phase (B-C):</strong> Represents a sharp upstroke when CO<sub>2</sub> containing alveolar gas is present at sampling site. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li><strong>Third Phase (C-D):</strong> Represents alveolar or expiratory plateau.</li>
<li><strong>Fourth Phase (D-E):</strong> Inspiration begins and fresh gas is entrained and touches baseline.</li>
<li>Phase C-D may take an upward slope. Point D is the highest CO<sub>2</sub> value and is called the End-tidal (ET CO<sub>2</sub>). ET CO<sub>2</sub> is the best reflection value ET CO<sub>2</sub>&agrave; 35 - 45 mmHg.</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 98</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The nurse noticed that the patient IV line is reddened, warm, painful and slightly edematous proximal to the insertion point of the IV catheter. While documenting the patient&rsquo;s condition which term will be used by the nurse? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Phlebitis</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Infiltration</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Hypersensitivity</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Allergic reaction</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Phlebitis means inflammation of a vein.</li>
<li>Thrombophlebitis is due to one or more blood clots in a vein that cause inflammation. Thrombophlebitis usually occurs in veins of leg, but it may occur in an arm or other parts of the body.</li>
<li><strong>Phlebitis</strong>: This is the inflammation of a vein, often occurring at the site of an IV catheter. It can present with symptoms such as redness (erythema), warmth, pain, and slight swelling (edema) along the vein. Phlebitis can be caused by irritation from the catheter, the infusing solution, or infection.</li>
<li><strong>Infiltration</strong>: This occurs when the IV catheter is no longer properly positioned in the vein, causing the IV fluid to leak into the surrounding tissue instead. Signs of infiltration include swelling, pallor, and coolness at the site, but it usually lacks the redness and warmth that are characteristic of phlebitis.</li>
<li><strong>Hypersensitivity</strong>: This term generally refers to an exaggerated immune response to a substance, which can lead to symptoms like rash, itching, or swelling. In the context of IV therapy, hypersensitivity reactions might occur due to medications or solutions infused but typically involve systemic symptoms rather than localized redness and warmth.</li>
<li><strong>Allergic Reaction</strong>: This is a specific immune response to an allergen, which may involve symptoms like hives, swelling, itching, or respiratory difficulties. An allergic reaction would usually present with more widespread symptoms rather than localized findings at the IV site.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 99</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Identify the image given below:</strong></p>
<p><strong><img title="5.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/30341572-0f8d-42a0-a3cd-7d5cb0fa5191.png" alt="" width="267" height="204" /></strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Negative pressure wound therapy</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>DVT pump</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Sequential compression device</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>None of the above</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Negative pressure wound therapy (NPWT) is a method of drawing out fluid and infection from a wound to help it heal. A special dressing (bandage) is sealed over the wound and a gentle vacuum pump is attached.</li>
<li>A black wound would be treated with autolytic debridement or negative pressure wound therapy</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 100</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Emergency contraceptive pills can be effective if used within:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>24 hours</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>48 hours</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>72 hours</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>96 hours</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Emergency contraceptive pills more effective in first 3 days (72 hours); after unprotected sex, but you can take them up to five days after. The sooner you take them, the better they work.</li>
</ul>
</body></html></li></ul></div></div>
        <div class="credits">
            <p class="rainbow-text">Credit: Code Written by BHASKAR</p>
        </div>
        </body></html>